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Abstract
YI LIU: Fast and Accurate Haplotype Inference
with Hidden Markov Model
(Under the direction of Wei Wang and Yun Li)
The genome of human and other diploid organisms consists of paired chromosomes.
The haplotype information (DNA constellation on one single chromosome), which is
crucial for disease association analysis and population genetic inference among many
others, is however hidden in the data generated for diploid organisms (including human)
by modern high-throughput technologies which cannot distinguish information from two
homologous chromosomes. Here, I consider the haplotype inference problem in two com-
mon scenarios of genetic studies:
1. Model organisms (such as laboratory mice): Individuals are bred through prescribed
pedigree design.
2. Out-bred organisms (such as human): Individuals (mostly unrelated) are drawn
from one or more populations or continental groups.
In the two scenarios, one individual may share short blocks of chromosomes with
other individual(s) or with founder(s) if available. I have developed and implemented
methods, by identifying the shared blocks statistically, to accurately and more rapidly
reconstruct the haplotypes for individuals under study and to solve important related
problems including genotype imputation and ancestry inference. My methods, based
on hidden Markov model, can scale up to tens of thousands of individuals. Analysis
iii
based on my method leads to a new genetic map in mouse population which reveals
important biological properties of the recombination process. I have also explored the
study design and empirical quality control for imputation tasks with large scale datasets
from admixed population.
iv
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Chapter 1
Introduction
Recent technological advances in life sciences have generated massive amounts of data
which enables accurate analyses of genome ancestry, recombination properties, complex
disease susceptibility, and drug response, among many others. However, it is often the
haplotype information that is more powerful in such analyses than the data directly
obtained from high-throughput technologies such as genotyping. Therefore, how to re-
construct haplotype information from massive amount of raw data and make related
inference based on recovered haplotype information are key problems in genetic studies
and pose serious computational challenge.
In this thesis, I have developed statistical methods and computational tools that, by
reconstructing haplotype information, generate accurate inferences for important prob-
lems including genome ancestry and imputation. My methods, based on Hidden Markov
Model (HMM), can efficiently handle large scale datasets from two common settings in
modern genetic studies:
1. Model organisms (such as laboratory mice): Individuals are bred through prescribed
pedigree design.
2. Out-bred organisms (such as human): Individuals (mostly unrelated) are drawn
from one or more populations or continental groups.
1.1 Background
1.1.1 DNA and Haplotype
Diploid species, which include nearly all mammals, carry paired homologous chromo-
somes, one inherited from each parent. A haplotype refers to the DNA sequence data
from one of the paired chromosomes. Within the same species, DNA sequences are
largely identical differing only slightly among individuals. Thus haplotypes are often
defined only at positions with sequence variations. Figure 1.1 shows a toy example of
two chromosomes with 15 sites and the two haplotypes defined at sites with variations.
Figure 1.1: Toy example of two chromosomes with haplotypes defined on three sites
containing variations
Haplotype knowledge describes how genetic materials are inherited from generation
to generation. It thus provides direct knowledge of genome ancestry and historical re-
combination events. Furthermore, utilizing haplotype sharing information, one can fill in
missing genotypes (imputation) [Li et al., 2009]. Haplotypes are also important to many
other fundamental problems in genetics. To name a few: (1) linkage analysis and linkage
disequilibrium patterns [Stephens et al., 2001; Wall et al., 2003]; (2) mapping complex
traits and diseases [Johnson et al., 2001; Altshuler et al., 2008]; (3) selection, evolution
and historical migration in population genetics [Sabeti et al., 2002; Merriwether et al.,
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1995]. In these problems, even if reconstructed with uncertainty, haplotype information
could lead to significantly increased power in inferences.
Even though it is possible to obtain haplotype information of diploid organisms di-
rectly from biological experiments, it is generally expensive and cannot scale to large sam-
ple size. On the contrary, modern high-throughput genotyping technologies can generate
accurate genotype readings on hundreds of thousands of markers at much lower cost. It is
thus valuable to conduct analysis by reconstructing haplotypes based on genotype inputs.
1.1.2 Genotype
Modern high-throughput genotyping technologies generate genotype readings on a pre-
selected set of genetic markers. The set of markers can be defined by standard commercial
platforms (e.g., Affymatrix 6.0, Illumina 1M), or customized by researchers (e.g., Yang
et al. [2009]). Each genotype reading, or simply genotype, is an unordered combination
of two alleles from paired chromosomes. In other words, genotypes are unable to dis-
tinguish between the two haplotypes of a diploid organism. It cannot tell which allele
is from which haplotype.
In this dissertation, I consider how to bridge the gap between genotype data and
desired genetic analyses by reconstructing haplotypes probabilistically. Here, I consider
two common settings in genetic studies and related inference problems specific to settings.
1.2 Model Organisms from Prescribed Breeding
Model organisms, such as laboratory mice, are frequently bred or crossed in order to
study genetic influences [Churchill et al., 2004; Valdar et al., 2006; Chia et al., 2005].
Often, organism resources are generated using prescribed breeding system to ensure di-
versity and reproducibility, which leads to complex pedigree structure consisting of many
generations. Through recombination, DNA sequences of founder organisms are inter-
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mixed in each generation. A DNA sequence of any descendant organism is a mosaic of
its founders’ DNA segments.
One example of such resources is the international Collaborative Cross (CC) project
which is a major effort in the mouse research community and has been under development
for more than 10 years [Threadgill and Churchill, 2012]. The CC project consists of
hundreds of independently bred, recombinant-inbred mouse lines generated through a
funnel breeding design (Figure 2.3). Each line has more than 20 expected generations.
High-density genotype data of the CC resources not only provide opportunities for fine-
resolution quantitative trait locus (QTL) studies, but also facilitate exciting new research
areas such as the inference of genetic networks underlying phenotypic traits in mammals.
Among many analyses of interest, a core problem is to discover the founder attribution
to genomes in subsequent generations. That is to say, given a descendant organism
in the resource, I want to find out which part of its DNA sequences is inherited from
which founder (genome ancestry in founders). The genome ancestry information provides
direct knowledge of historical recombination events and opportunities for error detection
and imputation. It also enables downstream analyses such as measuring strain effect
in quantitative traits.
Inference of genome ancestry involves resolving the potential inheritance flow at all
markers of interest. This naturally requires the resolution of haplotype information as
haplotypes correspond to the variants inherited together in the breeding process. It is
straightforward to show that, in a pedigree with n non-founders andmmarkers of interest,
there are 2mn possible inheritance configurations even if one assumes known founder
haplotypes and only bi-allelic markers. In a typical CC pedigree, there could be more
than 40 mice and the enormous search space presents a major computational challenge.
The commonly favored pedigree-based haplotyping methods [Kruglyak et al., 1996;
Abecasis et al., 2001; Gudbjartsson et al., 2005] are all based on the Lander-Green algo-
rithm (Lander and Green, 1987) as the running time is linear to the number of markers
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which far exceeds other parameters. However, these methods are limited to pedigrees
of moderate size since the running time grows exponentially with pedigree size. When
they are applied to the genotype data from CC, the search space becomes extraordinarily
large due to the large pedigree structure with many untyped intermediate generations.
Other pedigree-based haplotyping methods include MCMC sampling methods [Sobel and
Lange, 1996; Jensen and Kong, 1999], whose computing time can be substantial when
applied to a large number of tightly linked markers, and rule-based methods [Qian and
Beckmann, 2002; Li and Jiang, 2005], which have a crude approximation by minimiz-
ing recombinations in pedigree. More computationally efficient approaches for solving
the genome ancestry problem have ignored pedigree information, including the breed-
ing scheme. Examples include the combinatorial optimization approach by Zhang et al.
[2008] and the HMM-based method in HAPPY [Valdar et al., 2006; Mott et al., 2000], a
QTL mapping tool suite for association studies. All ancestry compositions are considered
possible in the two methods. While breeding design does not determine the locations
of recombination, it places important constraints on the possible ancestry choices at
a single marker and at neighboring markers. Therefore, incorporating breeding design
information would lead to more accurate inference.
1.3 Samples from Out-bred Human Populations
The ultimate goal of almost all genetic research is to understand genetic mechanisms in
humans. Therefore, tremendous efforts have been spent on investigating human samples
directly. In contrast to model organisms where breeding is often designed and controlled,
humans are out-bred and the genetic data of founders are generally unavailable. Since
Risch and Merikangas [1996] showed that association studies are more powerful than
linkage studies, genetic data collected for humans in the past one and a half decades
are largely from unrelated individuals. The consequence of out-breeding, lack of founder
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genetic information, and use of unrelated individuals is that individuals studied tend to
share only short haplotype segments (e.g., several hundred Kbs) of their chromosomes.
This is further confounded by the presence of population and sub-population structure.
Reconstruction of haplotype in such out-bred populations is therefore challenging but
of great importance in genetic studies.
By aligning samples under study to samples in existing studies (e.g., HapMap and
1000 Genomes projects [The International HapMap Consortium, 2010; The 1000 Genomes
Project Consortium, 2012]), researchers can identify the shared haplotype segments
among samples. Consequently, one can not only recover the sporadic technological fail-
ures in genotypes, but also impute the markers that are untyped in individual studies
but typed in reference samples. This genotype imputation technique greatly improves
the marker density and analysis power of individual studies.
Moreover, as the typical small to moderate effect of individual genetic variant on
complex trait entails large sample size, collaborative efforts that pool information across
multiple studies are typically taken to enhance the statistical power for detecting causal
variants. In these collaborative efforts, samples from different studies are typically geno-
typed at different sets of markers because different commercially available genotyping
platforms are used. The commonly used genotyping platforms have a small fraction of
markers in common (∼10% is typical between platforms from two different companies).
Restricting analysis to markers in common leads to much reduced marker density and
huge loss of information. Imputation of markers untyped in individual studies greatly
facilitates the integration of samples across studies (meta-analysis) .
Several HMM-based imputation methods [Li et al., 2010a; Howie et al., 2009; Brown-
ing and Browning, 2009] have previously been developed by reconstructing the haplo-
types and shown to achieve good imputation performance in a number of populations
[Pei et al., 2008; Huang et al., 2009], particularly those with high level of linkage dis-
equilibrium (LD) or having closely matched reference population(s) from the HapMap
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or the 1000 Genomes Projects [The International HapMap Consortium, 2010; The 1000
Genomes Project Consortium, 2010]. The wealth of literature using genotype imputa-
tion has focused on using external reference panels (for example, phased haplotypes from
the HapMap and 1000 Genomes projects), largely in individuals of European ancestry,
for inference of genotypes at common (minor allele frequency [MAF] > 0.05) genetic
markers. Several important issues have not been adequately addressed including the
utility of study-specific reference, accommodation of increasingly large reference panels,
performance in admixed populations, and quality for less common (MAF ∼ 0.005-0.05)
and rare (MAF < 0.005) variants. These issues only recently became addressable with
Genome-Wide Association (GWA) follow-up studies using dense genotyping or sequenc-
ing in large samples of non-European individuals.
Also, little methodological work exists for imputation in admixed populations, such
as African Americans and Hispanic Americans, which comprise more than 20% of the US
population. Admixed populations offer a unique opportunity for gene mapping, but also
impose challenges for imputation. To efficiently benefit from emerging large reference
panels, one key issue to consider is on how to traverse the reference space harboring the
most probability mass with minimum computational efforts. In modern genotype impu-
tation framework, this corresponds to the selection of effective reference panels. Existing
works often focused on constructing a pre-defined reference panel prior to running
the imputation engine. Such methods (e.g., a cosmopolitan panel [Hao et al., 2009; Li
et al., 2009; Shriner et al., 2010] or a weighted combination panel [Egyud et al., 2009;
Huang et al., 2009; Pasaniuc et al., 2010; Pemberton et al., 2008]) have limited flexibil-
ity and aggravate the already heavy computation burden. Another approach, based on
whole-haplotype closeness heuristics, has been adopted by IMPUTE2 [Howie et al., 2009]
and can be embedded within other existing imputation models. The above-mentioned
methods have shown promising results but have not been evaluated systematically. In
addition, both categories of methods can be further improved statistically and compu-
7
tationally, for example, through integration of the former approach within (rather than
prior to) the hidden Markov model, or through more elegant heuristics.
1.4 Thesis Statement
Genetic analyses of model organism resources and out-bred populations can be achieved
by reconstructing haplotype information implicitly or explicitly via HMM. By applying
effective state-space pruning strategies, I present haplotype-based inference algorithms
that can scale to large datasets without compromising accuracy. Application to CC mouse
data leads to new biological discovery of properties of recombination events. Case study
on Women’s Health Initiative (WHI) metabochip data leads to generalizable quality
control guidelines for imputation analysis.
1.5 Contributions
In this section, I briefly summarize the contributions presented in subsequent chapters.
1.5.1 Model Organisms from Prescribed Breeding
• In Chapter 2, I propose a method, GAIN, to infer genome ancestry in organism
resources. The method can efficiently handle complex pedigrees with inbreeding
which is an important process in generating organism resources. Using a pair of
dependent quaternary indicators to capture all recombinations in the inbreeding
history, my method achieves accurate ancestry inference without the need to ex-
plicitly model every intermediate generation. By encoding the inbreeding model
into the inheritance vectors, I design a Lander-Green-like algorithm whose running
time remains constant with respect to the number of inbreeding generations. GAIN
is implemented and evaluated on the CC high-density single-nucleotide polymor-
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phism (SNP) data with complex breeding design. Experiments show that, GAIN
generates accurate results efficiently on data that cannot be handled by existing
pedigree haplotyping software. Compared with HAPPY [Mott et al., 2000], which
does not model pedigree structure, GAIN substantially reduces ambiguities in an-
cestry inference.
• In Chapter 3, I generate a new linkage map of the laboratory mouse genome using
GAIN described in previous chapter. The map is built with the recombination
and ancestry information inferred from the genotypes of 237 male-female sibling
pairs. Exploiting the large number of recombination events (n∼22,000), the high
precision in mapping each event (∼35kb) and the unique characteristics of the CC
mice, I provide a new and powerful look at the effects of sex, strain and genotypes at
polymorphic loci of interest (e.g., the Prdm9 gene) on recombination. In addition to
an extended catalog of sex and strain specific hotspots, I report the presence of cold
regions for recombination with striking distributions and genomic characteristics.
1.5.2 Samples from Out-bred Human Populations
• In Chapter 4, I propose and evaluate a number of methods for effective refer-
ence panel construction to improve haplotype-based imputation engines. Using
a novel piecewise IBS method, my software package MaCH-Admix yields con-
sistently higher imputation quality than existing methods/software. I evaluated
the performance on individuals from recently admixed populations, including 8421
African Americans and 3587 Hispanic Americans from the Women’s Health Initia-
tive (WHI), which allow assessment of imputation quality for uncommon variants.
The advantage is particularly noteworthy among uncommon variants where up
to 5.1% information gain is observed with the difference being highly significant
(Wilcoxon signed rank test P -value < 0.0001). This work is the first that considers
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various sensible approaches for imputation in admixed populations and presents a
comprehensive comparison.
• In Chapter 5, I present a case study of imputation in a large cohort of African Amer-
icans from the Women’s Health Initiative (WHI) study. This study presents three
under-studied aspects: (1) imputation of markers from a region-centric platform
that are largely of low frequency; (2) imputation using a study-specific reference
panel; and (3) imputation in admixed population. In this study, I describe a pipeline
for constructing study-specific reference panels using individuals genotyped or se-
quenced at a larger set of genetic markers and for imputation into individuals with
genotype data at a subset of markers. I demonstrate several approaches to reliably
estimate imputation quality for SNPs in different MAF categories. Experiment
results suggest that imputation of region-centric SNPs, including low frequency
SNPs with MAF 0.005-0.05, is feasible and well worthwhile for power increase in
downstream association analysis. I further provide practical guidelines regarding
post-imputation quality control.
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Chapter 2
Efficient Genome Ancestry Inference
in Complex Pedigrees with
Inbreeding
2.1 Introduction
Model organisms, such as laboratory mice, are frequently bred or crossed in order to
study genetic influences [Churchill et al., 2004; Valdar et al., 2006; Chia et al., 2005].
Often, such animal resources are generated using prescribed breeding system to ensure
diversity and reproducibility, which leads to complex pedigree structure consisting of
many generations. Through recombination, the DNA sequences of founder organisms are
intermixed in each generation. A DNA sequence of any descendant organism is a mosaic
of its founders’ DNA segments. As recombinations at each breeding stage cannot be
observed directly, it is of great interest to infer the ancestry of resulting DNA sequences.
In other words, which part of a resulting DNA sequence is inherited from which founder.
The vast majority of the sequence variations are attributed to single base-pair mu-
tations known as single-nucleotide polymorphism (SNPs), thus making SNPs ideal for
resolving the genome ancestry problem. The set of SNPs on the same chromosome con-
stitutes a haplotype. While any of the four nucleotides (A,T,C,G) is possible, in practice
nearly all SNPs appear in only two variations. This results from the fact that SNPs
originate as mutations, which are rare events within a vast genome. It is therefore con-
venient to encode a SNP allele as a binary value and represent haplotypes as binary
sequences. Modern high-throughput genotyping technologies are unable to distinguish
between the two haplotypes of a diploid organism. Instead, a genotype sequence is mea-
sured where, at each SNP site, one of three possibilities is observed ({00, 01, 11}, since
10 cannot be distinguished from 01).
Using the genotype representation for DNA sequences, the genome ancestry problem
estimates the origin of each genotype from a descendant’s sequence given the genotype
sequences of its distant founders. To achieve high resolution, dense SNP markers are
used ( tens of thousands on each chromosome ). Knowledge of genotype’s ancestry is
particularly useful in many problems such as studying the structure and history of haplo-
type blocks [Gabriel et al., 2002; Zhang et al., 2002; Schwartz et al., 2004], and mapping
quantitative trait loci (QTLs)[Valdar et al., 2006; Mott et al., 2000]. In these studies,
a probabilistic interpretation is favored over discrete solutions, due to the prevalence of
ambiguities and measurement errors.
The genome ancestry problem is closely related to haplotype inference with pedigree
data. Inferring haplotypes in a pedigree often involves solving the inheritance flow of
alleles at each generation. On the other hand, given the genome ancestry information,
it is straightforward to reconstruct the descendant haplotypes. As pedigree analysis is
NP-hard [Piccolboni and Gusfield, 2003], existing algorithms are either approximate or
suffer exponential running times. Among the maximum likelihood approaches, meth-
ods [Kruglyak et al., 1996; Abecasis et al., 2001; Gudbjartsson et al., 2005] based on
the Lander-Green algorithm [Lander and Green, 1987] are often favored because their
running time is linear to the number of markers. MERLIN [Abecasis et al., 2001], an
implementation based on sparse binary trees, is one of the most successful pedigree anal-
ysis programs. Unfortunately, methods based on Lander-Green algorithms are limited
to pedigrees of moderate size since the running time grows exponentially with pedigree
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size. MCMC sampling methods [Sobel and Lange, 1996; Jensen and Kong, 1999] have
been proposed to address larger pedigrees. But their computing time can be substan-
tial when applied to a large number of tightly linked markers. Other efforts include
rule-based methods [Qian and Beckmann, 2002; Li and Jiang, 2005] which approximates
a solution by minimizing recombinations in the pedigree (MRHC). PedPhase [Li and
Jiang, 2005], which employs an effective integer linear programming (ILP) formulation,
has been widely used in solving the MRHC.
Current haplotyping methods for pedigrees are incapable of solving the genome ances-
try problem in animal resources for the following reasons: 1) Pedigrees of model animal
resources often contain large number of generations to ensure diversity and reproducibil-
ity. 2) None or few of the intermediate generations are genotyped due to the size of the
resources. 3) A large number of dense markers are genotyped to achieve fine resolution.
As a concrete example, more than one thousand lines have been started in the Collabo-
rative Cross project [Churchill et al., 2004; The Collaborative Cross Consortium, 2012].
Each line is expected to undergo at least 23 generations before reaching 99% inbred.
Hundreds of mice of various generations were genotyped, but on average only few are
from the same line. The missing genotypes make the search space extraordinarily large.
Other computationally efficient approaches for solving the genome ancestry problem
have largely ignored the breeding scheme. While breeding design does not determine the
locations of recombination, it often places constraints on the possible ancestry choices
at a single site and at neighboring sites. The genome ancestry problem was modeled as
a combinatorial optimization problem in [Zhang et al., 2008]. By minimizing recombi-
nations, discrete solutions are generated. Mott et al. has proposed an approach using
Hidden Markov Model (HMM) for ancestry inference in HAPPY [Valdar et al., 2006;
Mott et al., 2000], a QTL mapping tool suite for association studies. All founder pairs
are considered as possible hidden states for emitting the observed genotype at each site.
Besides founder genotypes, no pedigree data are used in these two approaches.
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There have also been many efforts to analyze pedigree by identifying symmetries in
HMM state space [Donnelly, 1983; McPeek, 2002; Browning and Browning, 2002; Geiger
et al., 2009]. The states are then grouped to accelerate the calculation. However, finding
the maximal grouping is non-trivial. In real-world problems, only obvious symmetries
such as founder phase and chain structure in pedigree can be best utilized.
Besides model organisms, the genetic ancestry problem has been studied for human
individuals that have recently been admixed from a set of isolated populations, instead
of a set of founders[Tang et al., 2006; Sundquist et al., 2008; Sankararaman et al., 2008;
Pas¸aniuc et al., 2009]. In this problem, pedigree structure is usually not present (unre-
lated individuals) or the size of pedigree is small. Efficient methods have been developed
to handle large-scale datasets[Tang et al., 2006; Sundquist et al., 2008; Sankararaman
et al., 2008].
Leveraging the observation that large animal resource pedigrees often contain repet-
itive sub-structures, I propose a method that can efficiently handle complex pedigrees
with inbreeding which is an important process in generating animal resources. Using a
pair of dependent quaternary indicators to capture all recombinations in the inbreeding
history, my method achieves accurate ancestry inference without explicit modeling every
generation. By encoding the inbreeding model into the inheritance vectors, I design a
Lander-Green-like algorithm whose running time remains constant with respect to the
number of inbreeding generations. My method is implemented and evaluated on the
Collaborative Cross breeding design [Chesler et al., 2008; The Collaborative Cross Con-
sortium, 2012] with dense SNP data. Experiments show that, my approach generates
accurate results efficiently on data that cannot be handled by existing pedigree haplo-
typing software. Compared with HAPPY, which does not consider pedigree structure,
my approach significantly reduces ambiguities and errors in ancestry inference.
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2.2 The Genome Ancestry Problem
Given a pair of chromosomes, consider L SNP markers ordered by their chromosomal
locations. For each SNP site, we use 0 and 1 to encode the two possible values. The
genotype at each site is the unordered combination of corresponding alleles from both
chromosomes, which can assume one of three values: 00, 01, 11. A genotype sequence is a
genome-ordered set of genotypes denoted as: G = g1...gl...gL, (gl ∈ {00, 01, 11}). A hap-
lotype H = h1...hl...hL consists of alleles from one of the chromosomes where hl ∈ {0, 1}.
Consider a pedigree containing a set of founders FS = {F1, ..., FN} and a descendant
of interest. I denote the set of founder genotype sequences by {GF1, ..., GFN}, all of
which are given. Given the genotype sequence, GD, of the descendant generated through
the pedigree structure, its genome ancestry is to be determined. Every genotype gl in
GD inherits its alleles from two founders, say FA and FB. I refer to the founder pair
(FA, FB) as the genome ancestry at site l of genotype sequence GD. I want to estimate,
for every SNP site l, the probability P (Ancestry(gl) = (FA, FB)) for every founder pair
(FA, FB)∈FS×FS. Note that founder pairs are unordered ((FA, FB) = (FB, FA)), and
it is possible that FA = FB.
2.3 Modeling Inheritance in Pedigree
I start from the standard Lander-Green approach to model a pedigree: At each SNP
site, an inheritance indicator is used to indicate the outcome of each meiosis. These
inheritance indicators together form the inheritance vector. Since a child haplotype
inherits its allele from either the paternal or maternal sequence, an inheritance indicator
is a binary variable. For a pedigree with n non-founder animals, there are 2×n inheritance
indicators at each site. Hence, the inheritance vector at site l, vl, can be defined as a
binary sequence of length 2 × n. An instance of vl specifies a possible configuration of
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inheritance flow at site l of all animals in the pedigree. When SNP markers are dense
enough, one can assume at most one recombination between two sites in generating
one haplotype. If a recombination happens between site l and l + 1, the corresponding
inheritance indicator will have different states for the two sites. Hence, to measure the
number of recombinations between l and l + 1 in the whole pedigree, one can count
the difference in bits between vl and vl+1. The probability of having d recombinations
between l and l + 1 is θd(1 − θ)2n−d, where θ is the recombination fraction.
The length of inheritance vector grows linearly with the number of animals in the pedi-
gree and this causes exponential growth in the number of possible inheritance patterns.
Considering the fact that full pedigree analysis is computationally intractable, I overcome
the issue by modeling important sub-structure in breeding systems as a shortcut to effi-
cient computation. My first natural choice of sub-structure is inbreeding: 1) Inbreeding is
often used in model animal resources to generate genetically diverse and/or reproducible
descendants. 2) Inbreeding is often carried out for many generations and each generation
elongates the inheritance vectors by 4 bits. Hence, if a pedigree involves inbreeding, the
inbreeding generations often account for most of the computational complexity. I seek an
aggregated inheritance indicator to replace the collection of many inheritance indicators
in the inbreeding process. Such an aggregated indicator can be encoded in much shorter
length and incorporated into the inheritance vector. If the state and transition proba-
bility of the aggregated indicator can be modeled efficiently, full pedigree analysis will
become feasible on these animal resources. In the next section, I explain how inheritance
in inbreeding generations can be modeled as an aggregated indicator.
2.3.1 Modeling Inbreeding Generations
During inbreeding, offspring are produced by sibling matings for many generations. At
each generation, four new haplotypes are formed by recombining the four haplotypes
from the previous generation. The inbreeding process at a single site is shown in Figure
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(a) (b)
Figure 2.1: (a) Lattice of binary inheritance indicators representing the inheritance pat-
tern of an inbreeding process at a single site. (b) An equivalent quaternary indicator
representation
2.1(a). I denote the beginning generation of inbreeding as generation I0. Observe that, at
each site, because of the symmetry of inbreeding structure, the four alleles at generation
I0 have equal probabilities to be passed down to any haplotypes after I1. Thus, for a
descendant haplotype at generation Ik (k > 2), I can simply replace the lattice of binary
inheritance indicators by a single quaternary indicator. Each choice of the quaternary
indicator has 1/4 probability. Two quaternary indicators are needed for the two hap-
lotypes of a Ik descendant (Figure 2.1(b)). However, the two quaternary indicators are
not independent as the two haplotypes share the same inbreeding history until Ik−1. To
model this dependency between the two quaternary indicators, I find out the transition
events and probabilities of the pair of indicators. The grouped pair is then used as an
aggregated inheritance indicator as discussed above.
I label the four I0 haplotypes as 1, 2, 3, 4. I then denote by a, b the two Ik descendant
haplotypes and S(al), S(bl) are their I0 sources at site l, i.e., S(al), S(bl) ∈ {1, 2, 3, 4}.
Their I0 sources along the chromosome is denoted by S(a), S(b) ∈ {1, 2, 3, 4}
L. A transi-
tion happens in S(a) between site l and l + 1 if S(al) 6=S(al+1). I consider, between two
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adjacent sites, l and l + 1, all the possible transitions from S(al), S(bl) to S(al+1), S(bl+1)
(Table 2.1).
Note that:
PEE0 + PEN1 + PEE2 + PEN2 = P (S(al) = S(bl)) =
PEE0 + PEE2 + PNE1 + PNE2 = P (S(al+1) = S(bl+1))
and
PNE1 + PNN0 + PNN1 + PNN2 + PNE2 = P (S(al) 6=S(bl)) =
PEN1 + PEN2 + PNN0 + PNN1 + PNN2 = P (S(al+1) 6=S(bl+1))
The prior probability P (S(al) = S(bl)) at any site l is called the inbreeding coefficient
[Wright, 1922]. To calculate the probability, let ICk denote the inbreeding coefficient at
generation Ik. ICk can be computed recursively using ICk =
k−2∑
j=0
(
1
2
)k−j × (1 + ICj).
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Site l Possible Transitions Site l + 1 Denote By
S(al) = S(bl)
Neither S(a) or S(b) transitions. S(al+1) = S(bl+1) PEE0
Either S(a) or S(b) transitions, but not both. S(al+1)6=S(bl+1) PEN1
Both S(a) and S(b) transition to same value. S(al+1) = S(bl+1) PEE2
Both S(a) and S(b) transition, but to different values. S(al+1)6=S(bl+1) PEN2
S(al)6=S(bl)
Neither S(a) nor S(b) transitions. S(al+1)6=S(bl+1) PNN0
Either S(a) or S(b) transitions, but not both. S(al+1) = S(bl+1) PNE1
S(a) and S(b) become equal after the transition.
Either S(a) or S(b) transitions, but not both. S(al+1)6=S(bl+1) PNN1
S(a) and S(b) remain different after the transition.
Both S(a) and S(b) transition. S(al+1)6=S(bl+1) PNN2
S(a) and S(b) remain different after the transition.
Both S(a) and S(b) transition. S(al+1)6=S(bl+1) PNE2
S(a) and S(b) become the same after the transition.
Table 2.1: All possible transitions of S(a), S(b). Each type of transition is denoted by 3 characters. First two letters indicate the
equality of S(a), S(b) before and after the transition. Then followed by a digit indicating the number of transitions in S(a), S(b).
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Next, I derive the probabilities in Table 2.1. Consider that any transition in S(a) or
S(b) is caused by one or more recombinations in the inbreeding process (Figure 2.1(a)).
My calculation is based on the assumption that the recombination fraction, θ, is rea-
sonably small. Hence, for any haplotype c at generation Ij (1≤j≤k), I assume that any
single transition in S(c) is solely caused by one recombination in generating c or its an-
cestor haplotypes. In other words, a single transition in S(c) is not the result of multiple
recombinations in the pedigree. My assumption is generally true for dense SNP markers
where θ is usually well below 0.001. Under the assumption, if a transition in S(c) is
caused by a recombination in generating c itself, I define this to be a lead transition.
Intuitively, a lead transition is one not inherited from its ancestors. A lead transition in
c will change the I0 source of c and all descendant haplotypes inheriting the transition.
A lead transition is only possible when the two parental haplotypes of c have different
I0 sources. Hence, between two sites, a haplotype at generation j has a lead transition
with probability θ × (1 − ICj−1).
With the inbreeding coefficients calculated, I can derive the marginal probability of ob-
serving transition in one of the Ik haplotypes, P1T = P (S(al) 6=S(al+1)) = P (S(bl) 6=S(bl+1)).
Without loss of generality, I consider P (S(al) 6=S(al+1)) for haplotype a. S(a) will tran-
sition if a itself or any of its ancestor haplotypes has a lead transition. At generation
k, the lead transition happens with probability θ × (1 − ICk−1). For generation k − 1,
there are 2 possible ancestor haplotypes, each with 1
2
θ × (1 − ICk−2) chance of causing
a transition in S(a). For each generation j from 1 to k − 2, there are 4 possible ances-
tor haplotypes with probability 1
4
θ × (1 − ICj−1). Consider that, at one site, any two
haplotypes from the same generation cannot both be the ancestor of a. Thus, for any
generation j, the expected probability of causing transition in S(a) is θ × (1 − ICj−1).
Under my assumption, P (S(al) 6=S(al+1)) can be expressed by 1−
k∏
j=1
(1−θ×(1−ICj−1)).
I then derive the probability PEE2 that S(a) and S(b) have equal state at site l, and
both transition to another state at site l + 1. This event happens only if a haplotype c at
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some previous generation is the common ancestor of a, b and c has a lead transition. The
probability of c at generation j being the common ancestor of a and b is 1
4
ICk−j. The
probability that c has a lead transition is θ× (1− ICj−1). Again, consider the fact that,
at one site, any two haplotypes from the same generation cannot both be the common
ancestor of a and b. Thus, the probability of EE2 event caused by lead transition at Ij
(1≤j≤k − 2) is θ × (1 − ICj−1)ICk−j. Assuming a small θ, PEE2 can be calculated by
1−
k−2∏
j=1
(1− θ × (1− ICj−1)ICk−j).
Lastly I consider the probability PNN1. To simplify my discussion, assume that the
transition happens in S(a) (i.e. S(al) 6=S(al+1)) and it inherits a lead transition in hap-
lotype c of generation j. Since S(al), S(al+1) and S(bl) all have different I0 ancestry,
alleles from at least 3 distinct I0 haplotypes should be observed at generation j − 1. Let
PDistinct(m, j) be the probability of observing exactly m distinct I0 alleles at generation
j. PDistinct(3, j) and PDistinct(4, j) can be computed recursively using:
PDistinct(4, j) =
1
4
PDistinct(4, j − 1)
PDistinct(3, j) =
1
2
PDistinct(3, j − 1) +
1
2
PDistinct(4, j − 1)
Then, PNN1 is the probability that (1) at least 3 distinct I0 alleles are present at gen-
eration j − 1 and (2) a’s ancestor c at generation j has a lead transition between sites
l and l + 1 which is inherited by a (3) before and after transition, the I0 source of c
is different from that of b.
Under my assumption of a small θ, PNN2, PNE2, PEN2 are all sufficiently small and
can be ignored in calculating other probabilities. The intuition is as follows: if k is small,
there are few animals in the inbreeding lattice and the chance of observing multiple
transitions is rare; when k becomes larger, the probability P (S(al) 6=S(bl)) approaches 0
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rapidly and PNN2, PNE2, PEN2 are much smaller than P (S(al) 6=S(bl)). With P1T , PEE2
and PNN1 derived, I can easily solve all the rest probabilities in Table 2.1:
PNE1 = PEN1 =
1
2
(2× (P1T − PEE2)− PNN1)
PEE0 = ICk − PEE2 − PEN1
PNN0 = 1− ICk − PNE1 − PNN1
PNN2, PNE2, PEN2 are approximated by a small probability PNE1×PNE1. I use simu-
lation to validate the probabilities derived above. The results are shown in Figure 2.2.
For θ around 0.01, my method gives reasonably close approximation. For θ below 0.001,
my method is very accurate. The recombination fraction between dense SNP markers
is usually well below 0.001.
So far I have derived all event probabilities in Table 2.1. The transition probability
from (S(al), S(bl)) to (S(al+1), S(bl+1)) is the corresponding probability in Table 2.1
conditioned on P (S(al) = S(bl)) or P (S(al) 6=S(bl)).
2.3.2 Integrating the Inbreeding Model
I have argued that each inbreeding process can be modeled by two quaternary indicators
and their transition probabilities can be accurately approximated when θ is small. It is
then straightforward to integrate the inbreeding model into the original Lander-Green
model. I encode the two quaternary indicators using 4 binary bits in the inheritance
vector. Consider a pedigree containing i inbreeding processes and n′ other members not
involved in inbreeding. The inheritance vector vl at every site l now has length 2×n
′+4×i.
Each possible realization of vl is a hidden state in HMM. The transition probability from
vl to vl+1 is the product of transition probabilities of all binary indicators and pairs of
quaternary indicators. I can then solve the HMM using standard routine:
22
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0.7
 0.8
 0.9
 1
 5  10  15  20
Pr
ob
ab
ilit
y
Inbreeding Generation
θ=0.0001
θ=0.001
θ=0.01
(a)
 0
 0.0005
 0.001
 0.0015
 0.002
 0.0025
 5  10  15  20
Pr
ob
ab
ilit
y
Inbreeding Generation
θ=0.0001
θ=0.001
(b)
 0
 0.001
 0.002
 0.003
 0.004
 0.005
 0.006
 5  10  15  20
Pr
ob
ab
ilit
y
Inbreeding Generation
θ=0.0001
θ=0.001
(c)
Figure 2.2: Comparison of predicted probabilities and observed probabilities from
10000000 simulations. The data points in the figures are observed probabilities from sim-
ulations. The curves are derived from my formulas. (a) Predicted and simulated PEE0 for
θ = 0.01, 0.001, 0.0001. (b) Predicted and simulated PEN1 = PNE1 for θ = 0.001, 0.0001.
(c) Predicted and simulated PEE2 for θ = 0.001, 0.0001. I do not plot the case of θ = 0.01
in (b) and (c) because the values are much larger than that of the other two θ values.
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P (vl|GD) =
P (GD|vl)P (vl)
P (GD)
=
P (g1, ..., gl|vl)P (gl+1, ..., gL|vl)P (vl)
P (GD)
=
P (g1, ..., gl, vl)P (gl+1, ..., gL|vl)
P (GD)
=
α(vl)β(vl)
P (GD)
where
α(vl) = P (g1, ..., gl, vl)
β(vl) = P (gl+1, ..., gL|vl)
α(vl) and β(vl) can be solved recursively:
α(vl+1) =
∑
vl
α(vl)P (vl+1|vl)P (gl+1|vl+1)
β(vl) =
∑
vl+1
β(vl+1)P (vl+1|vl)P (gl+1|vl+1)
P (GD) is obtained from the calculated α(vl) and β(vl) at any site l:
P (GD) =
∑
vl
α(vl)β(vl)
The genome ancestry at site l is, for every founder pair (FA, FB),
P (Ancestry(gl) = (FA, FB)) =
∑
vl
P (vl|GD)
for all vl s.t. gl is inherited from (FA, FB).
24
Note that, if I place the bits of quaternary indicators at the end of inheritance vec-
tor, the recursive calculation of α and β can still greatly benefit from the Elston-Idury
algorithm [Idury and Elston, 1997].
2.4 Modeling the Collaborative Cross
The Collaborative Cross (CC) [Churchill et al., 2004; Chesler et al., 2008; The Collabora-
tive Cross Consortium, 2012] is a large panel of reproducible, recombinant-inbred mouse
lines proposed by the Complex Trait Consortium. Over a thousand of mouse lines have
been started among which several hundred lines are kept inbreeding. All mouse lines
are generated using eight genetically diverse founders via a common breeding scheme
designed to randomize the genomic contribution of each founder. It provides an ideal
platform for testing my approach.
2.4.1 The Breeding Scheme
CC mice are derived from 8 fully inbred founders using the 8-way funnel breeding scheme
shown in Figure 2.3(a). The chromosomes of the eight founders (shown in different colors)
are combined by two generations of crosses (labeled G1 and G2I0), followed by at least
20 inbreeding generations (G2I1 to G2I∞).
The positions of the 8 founders are not fixed. Permutations of the founders are
used to randomize the genomes and balance the founder contributions to the resulting
CC lines. This variation in initial positions imposes different ancestry constraints on
each line. Without loss of generality, I assume a founder order of F1F2F3F4F5F6F7F8
as shown in Figure 2.3(a).
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(a) (b)
Figure 2.3: (a) Collaborative Cross breeding scheme: An example derivation of chro-
mosomes by recombining chromosomes from 8 ordered founders. G1 and G2I0 are two
generations of crosses. G2I1 to G2I∞ are multiple generations of inbreeding. (b) The
inheritance indicators used to represent the inheritance flow at a SNP site.
2.4.2 Modeling the Genome of G2Ik Generation
In a CC pedigree, any recombination in the formation of G1 haplotypes can be virtu-
ally ignored since all founders are fully inbred. Hence, at each SNP site, I only need
4 inheritance indicators for G2I0 haplotypes and 2 quaternary indicators for the two
haplotypes in a resulting G2Ik descendant. The structure of the inheritance indicators
is shown in Figure 2.3(b).
G2I1 mice are an exception which only involve one generation of inbreeding. For a
G2I1 mouse, I simply let the two quaternary indicators revert back to binary indicators.
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This becomes a standard Lander-Green model and it can be seen that the two G2I1
haplotypes are restricted to be from the left and right half of the funnel respectively.
2.5 Experiments
In this section, I evaluate the proposed model on both simulated data and real CC geno-
type data. I implement my model GAIN (Genome Ancestry with INbreeding) for CC
using C++. GAIN is compared with MERLIN [Abecasis et al., 2001] and HAPPY [Mott
et al., 2000]. MERLIN is a widely used pedigree analysis software based on Lander-Green
algorithm and can handle large number of markers. HAPPY is a QTL mapping tool
suite and can analyze genome ancestry based on only founder and descendant genotype
data, i.e., it ignores pedigree structure. Both software estimate the genome ancestry
directly or indirectly.
2.5.1 Experiments on Simulated Data
As ground truth is generally unavailable for real data, I evaluate the accuracy of genome
ancestry analysis using simulated data. I simulate the genotype of a G2Ik mouse by
recombining real CC founder haplotypes according to the CC pedigree structure. Given
the founder genotypes, the founder haplotypes can be obtained trivially since all founders
are fully inbred. At each generation I choose recombination position randomly. To simu-
late genotyping errors, I also introduce random errors to the resulting genotype sequence.
When a site is selected to represent an error, I flip its value to heterozygous if it is ho-
mozygous originally. If a heterozygous site is selected, I change it to one of the homozy-
gous state randomly. This resembles the fact that most genotyping errors are between
heterozygous and homozygous states, instead of between the two homozygous states.
I simulate 20 test cases for each generation from G2I1 to G2I20. The number of mark-
ers ranges from 6 to 10 thousands. As MERLIN does not output probability distribution
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for each inheritance vector, I first compare the best founder ancestry pair estimated by
each method against the true answer. The error rate is measured by the percentage of
sites where the estimated best founder ancestry does not match the ground truth. Fig-
ure 2.4 shows the error rate of all three methods in the simulated data with and without
errors. Results of MERLIN are only available for the first 4 generations as the running
time grows exponentially with the size of pedigree. No results can be generated within
reasonable running time (3 hours) for generations beyond G2I4. By incorporating pedi-
gree information, both GAIN and MERLIN infer accurate estimates (error rate less than
2%). In contrast, HAPPY has much higher error rates and is more sensitive to noise.
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0  2  4  6  8  10  12  14  16  18  20
Er
ro
r R
at
e
Inbreeding Generation
MERLIN
GAIN
HAPPY
(a)
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0  2  4  6  8  10  12  14  16  18  20
Er
ro
r R
at
e
Inbreeding Generation
MERLIN
GAIN
HAPPY
(b)
Figure 2.4: (a) Comparison of error rates of GAIN, MERLIN and HAPPY on a simulated
data set with no noise. (b) Comparison on a simulated data set with 1% noise.
As mentioned previously, an accurate solution to the genome ancestry problem is
important to subsequent studies such as QTL analysis. In such studies, not only the
most likely genome ancestry is desired, but also the probabilities of each founder pair are
wanted. Hence, it is also important to evaluate the probability distribution generated
by each method. Both GAIN and HAPPY compute a probability distribution of each
founder pair being the ancestry at a SNP site. I investigate the proportion of prob-
abilities assigned to wrong founder ancestry. The result in Figure 2.5 shows that the
knowledge of pedigree structure is indispensable in solving the genome ancestry prob-
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lem. While HAPPY infers the most probable ancestry correctly for more than 80% of
the markers, it assigns near 60% of the total probabilities to wrong ancestry choices.
The mis-assigned probabilities could hamper further studies. With pedigree structure
modeled, GAIN can resolve most ambiguities and assigns only less than 4% of the total
probabilities to wrong ancestry.
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Figure 2.5: (a) Proportion of probabilities assigned to wrong ancestry by GAIN and
HAPPY on a simulated data set with no noise. (b) Proportion of probabilities assigned to
wrong ancestry by GAIN and HAPPY on a simulated data set with 1% noise.
2.5.2 Experiments on Real CC data
The data set consists of genotypes of all autosomes from 96 mice of generation G2I5 to
G2I12. The number of SNP markers on each chromosome ranges from 4122 to 35172.
Due to the running time constraint of MERLIN, I only compare GAIN with HAPPY
which does not consider pedigree structure. Since the true genome ancestry is unknown,
I investigate the difference between the results of the two approaches.
I compare both the best ancestry estimated and the full probability distribution of
each possible ancestry. The first comparison (Figure 2.6(a)) shows the percentage of
sites of which the best ancestry estimated by the two methods do not agree. The dif-
ference in best ancestry choice is very similar to that of my experiments on simulated
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data with random error: the results from the two methods differ by 20%. I further mea-
sure the difference in probability distributions quantitatively using Jensen-Shannon(JS)
Divergence [Lin, 1991] which is a smoothed and bounded divergence based on Kullback-
Leibler Divergence. The JS Divergence (JSD) between two probability distributions
p1 and p2 is defined as:
JSD(p1||p2) =
∑
i
p1(i) log2
p1(i)
1
2
p1(i) +
1
2
p2(i)
+
∑
i
p2(i) log2
p2(i)
1
2
p1(i) +
1
2
p2(i)
A low JS Divergence indicates high similarity between p1 and p2. The JS divergence
ranges between 0 and 2. Figure 2.6(b) compares the mean and standard deviation of
the JS Divergence between HAPPY’s results and ours over all markers and all 96 mice,
grouped by chromosomes.
Though I cannot compare the results against the ground truth for real CC data,
the source of difference are further investigated. Consider again the CC pedigree in
Figure 2.3(a). The initial four founder-mating pairs (F1, F2),(F3, F4), (F5, F6), (F7, F8)
cannot serve as ancestry for any genotypes of G2Ik descendants. This is because any
genetic material passed from a founder mating pair is carried by a single haplotype in
the G2I0 generation. These four founder pairs are thus invalid ancestry choices if the
pedigree structure is considered. As an example to show the improved inference due
to incorporating pedigree knowledge, the ancestry of chromosome 7 of a G2I6 mouse
inferred by GAIN and HAPPY are shown in Figure 2.7(a) and 2.7(b) respectively.
The most probable founder pair inferred by HAPPY agrees with GAIN’s result at most
sites. But their actual probabilities are often different. To quantify the extent to which
HAPPY assigns positive probabilities to invalid ancestry, at each site l, I aggregate the
probabilities of invalid ancestry and plot this “pedigree inconsistency” measure in Figure
2.7(c). I can see that, the difference between Figure 2.7(a) and 2.7(b) is largely influenced
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Figure 2.6: (a) The difference in best ancestry estimated by GAIN and HAPPY (b) The
average JS Divergence between results from GAIN and HAPPY on chromosome 1 to 19 of
96 real CC mice.
by the “pedigree inconsistency”. Moreover, the probability distributions of ancestry
choices at neighboring sites are not independent. Probabilities assigned to pedigree-
inconsistent ancestry can substantially influence the choice of ancestry at neighboring
sites. Such “propagated error” is sometimes the main cause of the JS Divergence between
HAPPY’s results and ours. As an example, Figure 2.7(d) shows a region in chromosome
1 from another G2I6 mouse where the propagated error is the main cause of divergence.
In this region, HAPPY does not assign significant probabilities to invalid ancestry choice,
except for a few sites at both ends of this region. But, in the middle part, HAPPY favors
ancestry choices that are one recombination away from these invalid ancestry choices.
To sum up, even partial pedigree knowledge causes a big difference in analyzing
genome ancestry. Though HAPPY can conduct analysis rapidly, its results on complex
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Figure 2.7: (a) Ancestry inference on chromosome 7 of a G2I6 mouse by GAIN (b) Ances-
try inference on chromosome 7 of the same mouse by HAPPY (c) The pedigree inconsistency
in (b), i.e. the aggregated probability assigned to ancestry that violates pedigree knowl-
edge. (d) A region in chromosome 1 from another G2I6 mouse where propagated error is
the main cause of divergence.
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pedigrees can be biased. On the other hand, my method can provide a pedigree consistent
inference in comparable running time.
2.5.3 Running Time Performance
For a pedigree containing i inbreeding processes and n′ members not involved in inbreed-
ing, the time complexity of GAIN is O(L×n′× 22n
′
× 28i) where L is the number of SNP
markers. For any G2Ik animal in CC pedigree, the time complexity remains the same.
The running time does not depend on the error rate of genotype data either. Figure 2.8
shows the running time comparison of GAIN, MERLIN and HAPPY.
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Figure 2.8: Average running time of the three methods on data set containing 6644
markers. The experiment is conducted on an Intel desktop with 2.66Ghz CPU and 8GB
memory.
2.6 Discussion
The development of high density SNP technology makes model animal resources a pow-
erful tool for studying genetic variations. It also makes any analysis on such resources
computationally challenging. In this chapter, I demonstrate that modeling repetitive
sub-structure of a pedigree can provide significant improvement in efficiency without
compromising accuracy. I introduce a novel method for modeling the inbreeding pro-
33
cess. Integrated into the Hidden Markov Model framework originally introduced by the
Lander-Green algorithm, my method can handle large pedigrees such as Collaborative
Cross efficiently. The inbreeding sub-structure model alone does not speed up the ances-
try inference for all types of pedigrees, but, as I have shown with the Collaborative Cross,
the computational benefit can be crucial for analyzing many model animal resources. In
analyzing such data, my method outperforms previous methods in terms of accuracy
and efficiency. I believe that sub-structure modeling is a promising approach for large
pedigree analysis, especially when specific types of pedigree are of interest.
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Chapter 3
High Definition Recombination Map
in a Highly Divergent Mouse
Population
3.1 Introduction
Recombination is an essential biological process in sexual reproduction as it ensures
accurate chromosome segregation during meiosis and also contributes significantly to
DNA repair and genetic diversity. Abnormal recombination can result in missegregation
and is associated with multiple developmental diseases [Hassold and Hunt, 2001]. Despite
its importance, the regulation mechanism for the rate and pattern of recombination is
largely unknown, although previous studies have shown the influence of factors, including
sex, chromosome, DNA sequence and hotspots [Robinson, 1996; Smagulova et al., 2011].
The Collaborative Cross (CC) provides a unique opportunity for the study of genome-
wide recombination. The CC is a large panel of recombinant inbred lines (RIL) currently
under development [Chesler et al., 2008; The Collaborative Cross Consortium, 2012]. It
is derived from eight genetically diverse founder strains, including five classical inbred
strains (A/J, C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ, and NZO/H1LtJ) and three wild-
derived strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ). The eight founder strains were
selected to capture a much greater level of genetic diversity than existing RIL panels
[Roberts et al., 2007]. Each of the independently bred lines has equal contributions from
all eight founder strains via a funnel breeding scheme (Figure 2.3(a)). The eight founder
strains are first intercrossed to generate the G1 generation. The G1 progeny are then
crossed to create the four-way G2I0 generation. The first eight-way progeny, the G2I1
s are then generated from a G2I0 × G2I0 cross
1. After this generation, CC strains
become inbred by repeated generations of inbreeding through sibling mating. At the top
of the funnel, the eight founder strains are arranged in order that is randomized and not
repeated across lines. The left four founders contribute to the left half of the funnel and
the remaining four contribute to the right half. I also denote the four pairs of founders
that are crossed to produce G1 progeny as four quarters of the funnel.
In this study, I focus on the G2I1 generation which has balanced genome contribution
from both sides of the funnel pedigree. The breeding pedigree leading to G2I1 generation
contains eight observable meioses (Figure 3.1). I denote the four at crossing G1 generation
as MGM , MGP , PGM , PGP and the four meioses at crossing G2I0 generation as
Mm, Mf , Pm, Pf . Using the genotype data of G2I1 generation, I reconstructed the
haplotype at G2I1 generation and inferred all switching points of genome ancestry which
correspond to past recombination events in the pedigree. With the design of the breeding
scheme, every inferred recombination event can be assigned uniquely to one of the eight
meioses. With all recombinations inferred and characterized by gender, meioses and
genetic features, this study presents a high definition genome-wide recombination map
and associated analysis of its properties.
1Other researchers have used G2 and G2F1 to denote G2I0 and G2I1 generations
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Figure 3.1: The CC funnel pedigree to G2I1 generation. In total there are eight meioses
in the pedigree.
3.2 Materials and Methods
3.2.1 The Genotype Data
The genotype data were obtained from 244 male-female sibling pairs at G2I1 generation
using a customized high-density genotyping array [Yang et al., 2009]. The array contains
623,124 SNPs that capture the known genetic variation in laboratory mouse. Before I
conducted haplotype reconstruction, I separated SNPs into high-quality and mid-to-low
quality groups by examining:
• Genotype completeness (>0.99)
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• Concordance between G2I1 mice, founder mice and partially availableG1 genotypes
I kept only 15∼25% of all SNPs on each chromosome in the high-quality group and
used only these high-quality SNPs for haplotype reconstruction and recombination infer-
ence. The mid-to-low quality SNPs were used later to help refine recombination bound-
aries. I also excluded samples2 and chromosomes 3 with exceptionally high discordance
rate in haplotype reconstruction.
3.2.2 Haplotype Reconstruction and Recombination Inference
I utilized the method GAIN to conduct haplotype reconstruction and recombination
inference. The method, as described in Chapter 2, is a hidden-Markov-model based
method that can model haplotype and recombinations with all pedigree knowledge in-
corporated. It has been shown that GAIN can perform analysis in the CC with both
high accuracy and scalability with respect to the pedigree size (proportional to number
of generations). For the specific G2I1 generation, the model constructed in GAIN is
similar to that in an efficient implementation of Lander-Green algorithm (e.g., MERLIN
[Abecasis et al., 2001]) because there are no further inbreeding generations. I performed
analysis on each funnel independently but jointly on the siblings in the same funnel. This
is because siblings can share recombinations and joint analysis can help resolve ambi-
guity on recombination locations and haplotype boundaries. Recombinations, however,
are not shared across funnels.
For each pair of G2I1 sibling mice, GAIN took the genotypes of the eight founder
mice and genotypes of the two sibling mice as input. In addition, it required the funnel
order of eight founders. It then inferred the founder ancestry (in probabilities) at each
SNP site by building a descendency model at each SNP and evaluating the probabilities
of recombining between adjacent SNPs. The founder ancestry at each SNP describes
2fourteen mouse samples or seven sibling pairs
3six samples’ chromosome 18 and four samples’ chromosome X
38
the probability that each pair of founders (e.g., C57BL/6J and CAST/EiJ) are the two
founders where the two alleles are inherited from. With pedigree knowledge considered
and careful QC steps, GAIN achieved a very high level of confidence in estimating the best
ancestry at most sites. More than 98% of the sites in all mice have the best ancestry choice
estimated with ≥ 0.99 probability. With the ancestry probability information, I could
define the haplotype blocks and recombinations trivially by tracing the most probable
founder ancestry along chromosomes. Each recombination event is described by:
• a mid-point where the most probable founder ancestry changes
• proximal and distal boundaries where the probability of the most founder ancestry
shrinks to a threshold
• proximal and distal ancestry founders on the recombining chromosome
• the type of meiosis it is associated to
The recombination interval inferred (from proximal to distal boundary) is expected to
contain the recombination event with high probability. Note that there are regions where
multiple founder ancestries have similar probabilities (due to lack of markers, low geno-
typing quality or similar DNA sequence in multiple founders). In such cases, long recom-
bination intervals were obtained and the recombination events cannot be determined
with high resolution.
Upon obtaining the recombination inference results, I further refined them with the
mid-to-low-quality SNPs filtered in the QC step. This was done by examining the con-
sistency at mid-to-low quality SNPs between founders, each G2I1 mice, and all G2I1
mice assigned the same ancestry. On average, this reduced the recombination intervals
inferred by approximately half.
Note also that GAIN fully enforces all constraints imposed by pedigree knowledge.
For example, two of the strongest constraints for G2I1 mice are:
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• For any SNP of any G2I1 mouse, the two alleles must come from different halves
of the funnel.
• Two siblings cannot inherit different alleles from one quarter funnel at any SNP
site.
If the input data contained errors (genotype data or funnel order), GAIN would infer
significantly more recombinations in order to satisfy the corresponding constraints. This
can be used as an effective indicator to identify and remove:
• Wrongly labeled funnels and mice
• Poorly performing and/or incorrectly mapped SNPs
3.3 Overview of the Recombination Map
Table 3.1: Summary of Identified Recombination Events in G2I1 Mice
Autosomes X chromosome
Meiosis # Type Sex of G2I1 Non-Shared Shared All Non-Shared Shared All Total
1 M f 3282 - 3282 183 - 183 3465
2 M m 3255 - 3255 150 - 150 3405
3 P f 2871 - 2871 - - - 2871
4 P m 2783 - 2783 - - - 2783
5 MGM f 826 756 1582 35 48 83
m 767 756 1523 35 48 83
all 1593 756 2349 70 48 118 2467
6 MGP f 733 730 1463 - - -
m 768 730 1498 - - -
all 1501 730 2231 - - - 2231
7 PGM f 807 766 1573 174 - 174
m 782 766 1548 - - -
all 1589 766 2355 174 - 174 2529
8 PGP f 740 745 1485 - - -
m 757 745 1502 - - -
all 1497 745 2242 - - - 2242
A total of 25,038 recombination events were identified in the 474 individual G2I1
mice. Of these 18,948 events are observed only once and 3,045 recombination events are
shared by the sib pair. Therefore, we have identified 21,993 unique recombination events
in our population, 21,368 on the autosomes and 625 on chromosome X. Table 3.1 presents
a summary of all types of recombination events identified.
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At a high level, I examined the correctness of the events by checking the ratio between
types of events (expected and observed). Firstly, the ratio of shared vs non-shared
events is expected to be 1:2 based on Mendel’s Law of Segregation. In the observed
data, non-shared events represent 67.3% of events in the MGM, MGP, PGM and PGP
meiosis (6,180 out of 9,177 events, the binomial test p-value is 0.17). This is consistently
observed in each type of meiosis: MGM, 67.8%; MGP, 67.2%; PGM, 67.5% and PGP,
66.8% (binomial test p-values are 0.25, 0.54, 0.42, 0.93). Secondly, there should not
be significant differences in the number of events in same type of meiosis (Mf vs Mm,
Pf vs Pm, MGM vs PGM and MGP vs PGP). The ratio of events observed is highly
consistent: Mf vs Mm, 1.02; Pf vs Pm, 1.03; MGM vs PGM, 0.975; and MGP vs PGP,
0.999 (binomial test p-values are 0.48, 0.25, 0.39, 0.88). Lastly, the ratio between (M+P)
events and (MGM+MGP+PGM+PGP) should be 4:3 ( 4
4+3
= .57) 4. I observed 12,191
and 9,177 events, respectively ( 12191
12191+9177
= .57, the binomial test p-value is 0.79).
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Figure 3.2: Distribution of recombination interval length in log-scale
4For one G2I1 mouse, we expect to observe four informative independent meiosis. But if we consider
two siblings, we expect to observe 4× 2− 1 = 7 meioses. Because each G1 meiosis has 0.25 probability
to be observed in both siblings
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On average, the resolution of recombination events is very high (Figure 3.2). The
median size of recombination interval is 35kbp. There are, however, some recombinations
that have very large uncertainty intervals (peak in Figure 3.2 between 1∼3Mbp). These
are mainly due to strain dependent identical-by-descent (IBD) regions or lack of genetic
markers in the interval. Based on the 21,993 identified unique recombination events,
a recombination density map that can be smoothed at different scales is constructed.
When smoothed with windows larger than 500kb, the G2I1 map is remarkably similar to
the map recently published but with much lower density of markers [Cox et al., 2009].
3.4 Sex Effect on Recombination
As expected, the total number of recombination events in autosomes is significantly
smaller in the male germline than in the female germline (10,127 events and 11, 241
events, respectively; binomial test p-value ≤ 3 × 10−14; Table 3.1). This sex difference
is also observed in the number of recombination events observed in each individual in
both G1 and G2 meioses. To investigate the possible causes of this difference, the effect
of the Prdm9 genotype on the size of the autosomal map was determined. One of
the eight founder strains of the CC, CAST/EiJ, carries the Prdm9a allele, four strains
(A/J, C57BL/6J, 129S1/SvImJ and NZO/HILtJ) carry the Prdm9b allele, two strains
(NOD/ShiLtJ and WSB/EiJ) carry the Prdm9c allele and the PWK/PhJ strain carries
the Prdm9d allele. There is a significant expansion of the female map length and a
reduction of the male map length in carriers of the Prdm9a allele (1,450 cM and 1,195
cM, respectively). There is also a significant contraction of the female map length and
an expansion of the male map length in carriers of the Prdm9d allele (1,300 cM and 1,325
cM, respectively). Finally, carriers of both Prdm9b and Prdm9c alleles have similar ratio
of female to male map lengths (Figure 3.3).
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Figure 3.3: Recombination map length of autosomes by Prdm9 allele
and gender
In addition to the sex differences in overall recombination, there are dramatic sex
differences in the pattern recombination events in the autosomes. Figure 3.4 shows the
distribution of recombination events along the autosomes in female and male meioses.
The most obvious difference is the increase in the density of recombination events in
the distal ends of chromosomes in male meiosis. In female meioses, there is a more
even distribution of recombination events along the autosomes (Figure 3.4(a)). In male
meioses, approximately half of the recombination events occur in the distal quarter of the
chromosomes and almost one third of events occur in the distal 10% of the autosomes
(data not shown). Comparison of the recombination density observed in single and double
recombinants reveals striking differences while preserving the increase in recombination
in the distal ends of the chromosomes (Figure 3.5). The most obvious difference is that
in double recombinants there are two peaks of high recombination rate separated by very
low recombination rate in the middle while in single recombinants the density proximal
to the distal peak remains basically constant. In double recombinants from male meioses,
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the distal peak is both higher and sharper than in singles and the proximal peak is lower
and much wider. This pattern suggests that recombination may progress temporally
from the telomere to centromere in males.
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Figure 3.4: Distribution of recombination events along the autosomes in female and male
meioses. The x-axis corresponds to the relative position in all autosomes. The y-axis
indicates the kernel density estimates of recombinations in each type of meiosis.
3.5 Cold Regions
Regions with low levels of recombination have been reported previously [Smagulova et al.,
2011] and many mouse researchers have anecdotal evidence that the ability to efficiently
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Figure 3.5: Distribution of single and double recombination events along the autosomes in
female and male meioses. The x-axis corresponds to the relative position in all autosomes.
The y-axis indicates the kernel density estimates of recombinations in each type of meiosis.
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reduce the size of many candidate regions of interest is undermined by an apparent lack
of recombination. However, we know very little about the size, distribution, genomic fea-
tures and evolutionary stability of such regions. Thus identification and characterization
of such cold regions may provide important information on the distribution of genetic
variation and the level of linkage disequilibrium in the mammalian genome, the accuracy
of imputation of genetic variants and may provide new models to study the molecular
and cellular mechanisms of meiotic recombination.
3.5.1 Identification of Cold Regions in the G2I1 Population
Cold regions are defined as long (>500 kb) continuous genomic intervals that are markedly
depleted of recombination events in the G2I1 population. Given the total number of
recombination events in my experiment (∼22,000) I set up this 500 kb threshold in
the initial identification of cold regions to reduce the number of false positives (i.e., on
average I expect 8.7 recombination events per Mb).
The 50 coldest regions in male and female meioses are first identified independently to
allow for possible cold regions on chromosome X. The union of these regions constituted
the initial set and underwent several filtering steps. In the fist step regions in which
no calls (Ns) represent a large fraction of the nominal length are excluded. After this
step the boundaries of the 59 remaining cold regions are refined using the recombination
intervals in the G2I1 population. For 51 of these regions the new refined interval has no
recombination events and they are bound by the distal boundary of proximal recombi-
nation event and the proximal boundary of the distal recombination event (Table 3.2).
Overall, cold regions span 124.1 Mb (∼5% of the genome), distributed along 18 chromo-
somes (all chromosomes have cold regions except chromosomes 10 and 11) and with an
enrichment for proximal and distal sections of the chromosomes (Table 3.2)
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3.5.2 External Validation of Cold Regions
To determine whether the results in the G2I1 population are replicable in other popula-
tions, I estimated the recombination rate in these regions in the heterogeneous stock used
to construct the most recent linkage map of the mouse [Cox et al., 2009]. On average,
there is a four-fold reduction in recombination density in cold regions (0.14 cM/Mb ver-
sus the expected 0.5 cM/Mb that is observed genome wide). In fact, 57 of the 59 regions
are below the genome wide average and for 16 regions the recombination density in the
Cox map is zero (Table 3.2). The extent of validation is striking given the differences in
genetic background (only five of the 16 strains are shared between these two studies and
the non shared strains include three wild derived strains representing two subspecies that
are rare or absent in the genetic makeup of the strains in the Cox study), marker density
and approach to estimate recombination distances between these two populations.
Recently, several maps of recombination initiation sites in the mouse have been pub-
lished [Smagulova et al., 2011; Brick et al., 2012]. These studies identified regions with
significant enrichment of double strand breaks (DSB) in the male germline of mice of dif-
ferent genetic backgrounds. Smagulova et al. [2011] identified 21 recombination deserts
larger than 3 Mb, but noted that the inability of identifying hotspots in some of these re-
gions may be due to sequencing gaps or highly repetitive DNA. Eleven of the cold regions
identified in the G2I1 population overlap with those described previously in Smagulova
et al. [2011]. This level of concordance is even more remarkable once one considers that
one of the Smagulova desserts was eliminated from my analysis because of complete lack
of sequence 5 and the fact that nine additional regions that fail to make the cut in my list
still show low levels of recombination in the G2I1 population. More importantly, data
from the second study [Brick et al., 2012] can be used to estimate the density of DSB
in any given region. On average there is a 18X reduction in DSB density (range 14X to
24X) in cold regions compared to the genome average.
5chr 7: 39 Mb, see also new GRCm38 assembly of the mouse genome
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Table 3.2: List of Cold Regions Identified
Chr Start End Size G2I1 Cox B6 9R 13R F1 Smagulova (C+G) SD genes
1 7552017 8916100 1364083 0 0 2.217 2.37 3.112 3.511 No 38.29 0.06 6
1 16629188 17556666 927478 0 0.234 3.065 2.903 3.502 3.573 No 40.12 0 11
1 26449654 29071537 2621883 1 0.069 2.621 2.468 2.425 2.481 Yes 36.53 0.35 14
1 47989803 50296981 2307178 1 0 2.794 2.566 2.526 2.689 No 36.58 0.25 11
1 100644783 101554230 909447 0 0.198 3.001 2.845 1.939 0 No 37.72 0 2
1 111488506 113990313 2501807 0 0.048 2.802 2.653 2.278 2.652 No 36.46 0.22 11
1 147042689 150558199 3515510 1 0.031 2.638 2.523 2.372 2.654 No 36.39 0.58 7
1 151085005 152671374 1586369 0 0.228 3.115 2.949 3.307 3.731 No 39.01 0.08 13
2 80863558 82092319 1228761 0 0.103 3.171 3.027 3.402 3.853 No 36.79 0 1
2 99031585 101085143 2053558 0 0.292 3.669 3.546 2.783 3.546 No 36.99 0.29 6
3 5879218 7942959 2063741 0 0.092 2.944 2.799 3.221 3.495 No 38.02 0.22 12
3 12781208 13766597 985389 0 0 3.378 3.178 3.661 3.938 No 37.08 0 4
3 71924425 72840203 915778 0 0 3.216 3.039 3.127 3.039 No 36.30 0 1
3 91404734 92463929 1059195 0 0 2.564 1.984 3.591 4.034 No 38.83 0.34 35
3 93110421 94190526 1080105 0 0.271 2.486 2.042 3.32 3.923 No 41.99 0.54 37
3 111864347 114650278 2785931 0 0.134 2.511 2.358 2.267 2.258 No 36.95 0.40 19
4 3872920 4995031 1122111 0 0.334 3.777 3.509 3.527 3.857 No 39.69 0 9
4 71515502 73850480 2334978 0 0 3.268 3.113 3.171 3.589 No 38.71 0.33 21
4 78445659 80238398 1792739 0 0.126 2.43 2.341 2.572 2.627 No 36.77 0.06 3
4 109873098 110836231 963133 0 0.04 1.802 0 3.721 4.03 No 38.3 0 1
4 112348832 113862435 1513603 0 0 0 0 1.744 2.235 No 37.23 0.18 9
4 123025109 124537945 1512836 0 0.332 3.105 2.871 2.644 2.703 No 45.89 0.01 23
5 7624169 8730184 1106015 0 0.055 3.684 3.543 3.315 3.4 No 39.83 0.03 10
5 10717204 11949724 1232520 0 0.126 2.316 1.985 0 0 No 37.77 0.89 25
5 86051378 89055526 3004148 0 0.083 3.682 3.384 3.392 3.784 No 38.19 0.52 59
5 93726598 96365273 2638675 0 0 0 0 0 1.995 No 41.00 0.94 46
6 129843394 131358958 1515564 0 0 0 0 2.671 2.998 No 38.22 0.63 29
7 7231821 12298098 5066277 0 0.584 1.989 1.7 1.843 1.999 Yes 38.98 0.92 157
7 20689345 24188289 3498944 0 0.073 0 0 0 1.66 Yes 40.94 0.97 157
7 31943682 34982574 3038892 0 0.051 2.747 2.438 1.5 1.743 Yes 41.14 0.90 71
7 66503334 69332558 2829224 0 0.138 3.048 2.889 2.713 3.045 No 41.74 0.80 27
7 91783502 92931816 1148314 0 0.06 0 0 0 0 No 37.85 0.06 31
7 110909130 111734201 825071 0 1.017 3.23 3.083 1.947 0 No 40.43 0.10 55
7 113744664 114326885 582221 0 0.151 2.355 2.264 2.509 2.729 No 39.04 0 29
8 75489675 77295059 1805384 1 0.241 2.977 2.82 3.264 3.557 No 40.02 0.10 3
9 4932310 6150379 1218069 0 0 2.685 2.556 3.252 3.646 No 37.72 0 7
9 8055696 9141014 1085318 0 0 2.879 2.665 0 0 No 39.83 0 8
12 21307827 25245820 3937993 0 0.048 2.257 1.962 0 1.387 Yes 44.85 0.96 47
12 47788818 49655054 1866236 0 0.169 3.338 3.178 3.054 3.181 No 36.77 0.06 4
12 61325419 62237566 912147 0 0.229 2.856 2.706 3.026 3.206 No 36.70 0 4
12 119492704 120437290 944586 0 0 2.906 2.661 2.563 2.974 No 40.08 0 6
13 16817515 18417648 1600133 0 0.318 3.713 3.296 3.39 3.691 No 39.45 0.08 12
13 85193045 87485288 2292243 1 0.021 2.747 2.604 1.635 1.74 No 37.43 0.26 8
14 13925179 19817805 5892626 0 0.191 3.727 3.568 3.323 3.68 No 40.89 0.79 47
14 42010628 43812329 1801701 0 0.063 0 0 0 0 No 41.37 0.89 34
14 50370810 51760945 1390135 0 0.423 2.947 2.695 3.467 3.692 No 40.24 0.20 54
14 83838558 86170267 2331709 0 0 1.67 0 2.3 2.394 No 36.39 0.25 5
14 123768455 124578293 809838 0 0.305 3.134 2.887 2.806 3.209 No 37.98 0 3
15 14228552 15476602 1248050 0 0.19 2.084 0 2.708 2.866 No 36.63 0 1
16 46467540 47489432 1021892 1 0.098 2.684 2.509 2.643 2.535 No 38.16 0.029 4
17 18006880 21070398 3063518 0 0.26 0 1.551 2.08 2.54 Yes 37.32 0.70 69
17 38288007 40000987 1712980 0 0.111 1.906 1.739 0 0 Yes 37.23 0.28 17
18 17782801 18654834 872033 1 0 0 0 0 0 No 36.74 0 1
19 12545972 14689226 2143254 2 0.217 3.373 3.132 3.54 3.937 No 38.89 0.19 84
X 23031354 33248619 10217265 0 0.294 1.331 0.93 2.883 2.411 Yes 39.61 0.87 0
X 73163204 76792464 3629260 0 0.023 4.164 3.967 3.749 4.161 Yes 39.15 0.58 0
X 110686456 112707404 2020948 0 0 3.226 3.081 3.282 3.753 No 37.25 0.24 0
X 115246562 118828417 3581855 0 0.057 2.365 2.381 3.319 3.706 Yes 36.69 0.63 0
X 143956636 146641734 2685098 0 0 1.349 0 2.679 2.737 Yes 40.61 0.91 0
The table provides the chromosome location of 59 putative cold regions identified in the G2I1 population. In addition
to the size of these regions, the table lists:
G2I1, number of recombination events in the cold regions in the G2I1 population.
Cox, recombination rate in Cox et al. [2009]
B6, log10(number of reads at DSB/Mb) in the C57BL/6J strain of the Brick et al. [2012]
9R, log10(number of reads at DSB/Mb) in the 9R strain of the Brick et al. [2012]
13R, log10(number of reads at DSB/Mb) in the 13R strain of the Brick et al. [2012]
F1, log10(number of reads at DSB/Mb) in the (9Rx13R) strain of the Brick et al. [2012]
Smagulova, recombination dessert in reported by Smagulova et al. [2011] in (C57BL/10.SC57BL/10.F)F1 mice
(C+G), base composition in percent
SD,fraction of the interval included in segmental duplication identified using dotplots generated using Gepard
[Krumsiek et al., 2007]
# genes, number of genes
48
3.5.3 Genomic Analysis of Cold Regions
Several genomic features have been associated with suppressed recombination in regions
such centromeres including low C+G content, frequent and complex duplications and
enrichment for repeated sequences. Therefore, I determined the content of cold regions for
these and additional genomic features (gene content, presence of segmental duplications
(tandem and inverted)).
The overall C+G content in cold regions is significantly lower than the genome wide
average (Table 3.2). When all 59 intervals are plotted together the plot resembles the
aggregate of three different distributions with obvious peaks at 36%, 40% and 44%. The
lower peak is the most pronounced and represents approximately half of the cold regions
(26 cold regions with low C+G). This suggests that cold regions tend to be associated
with local low C+G content. I also observed a highly significant enrichment for large
(>15 kb) segmental duplications either in tandem or inverted in cold regions. On average,
in cold regions 28% of the sequences are involved in some type of rearrangement.
3.6 Conclusion
In this chapter, I present a genome-wide recombination study based on recombination
events inferred from the G2I1 generation in the CC resource. The unique design of the
CC allows us to fully determine the meiosis of each recombination event and attribute
recombinations to gender and other genetic features. I performed careful quality control
steps in constructing the recombination map. Extensive internal and external validations
have been done to verify the correctness of results obtained. The sex, jointly with Prdm9
alleles, have strong effect on the pattern of recombinations. The distribution of double
recombinants in male meioses strongly suggests a temporal pattern of the recombina-
tion progression. Furthermore, the vast majority of cold regions identified in the G2I1
population represent bona fide regions of suppressed recombination independent of the
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genetic background. Besides establishing the association with reduction in DSB density,
I investigated the relationship between cold regions and local DNA sequence.
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Chapter 4
MaCH-Admix: Genotype
Imputation for Admixed Populations
4.1 Introduction
Imputation of untyped genetic markers has been routinely performed in genome-wide
association studies (GWAS) [Sanna et al., 2010; Scott et al., 2007; WTCCC, 2007] and
meta-analysis [Dupuis et al., 2010; Smith et al., 2010; Willer et al., 2008], and will con-
tinue to play an important role in sequencing-based studies [Fridley et al., 2010; The
1000 Genomes Project Consortium, 2010]. Li et al. [2010a] have previously developed a
hidden Markov model (HMM) based method for imputation and shown that it achieves
high imputation accuracy in a number of populations [Huang et al., 2009], particularly
those with high level of linkage disequilibrium (LD) or having closely matched reference
population(s) from the HapMap [The International HapMap Consortium, 2010] or the
1000 Genomes Projects (1000G) [The 1000 Genomes Project Consortium, 2010, 2012].
However, little methodological work exists for imputation in admixed populations, such
as African Americans and Hispanic Americans, which comprise more than 20% of the
US population (see Web Resources).
Admixed populations offer a unique opportunity for gene mapping because one could
utilize admixture LD to search for genes underlying diseases that differ strikingly in preva-
lence across populations [Reich and Patterson, 2005; Rosenberg et al., 2010; Tang et al.,
2006; Winkler et al., 2010; Zhu et al., 2004]. Although useful for admixture mapping,
admixture LD also imposes challenges for imputation. Since an admixed individual’s
genome is a mosaic of ancestral chromosomal segments, to appropriately impute the
genotypes, it is imperative to incorporate the underlying ancestry information. Prac-
tically, this is equivalent to selecting an appropriate reference panel that matches the
corresponding ancestral population(s).
Existing studies have evaluated a wide range of choices on the construction of a
reference panel prior to running the imputation engine. The recommendation is to use a
pre-defined panel that either combines all reference populations (a cosmopolitan panel)
[Hao et al., 2009; Li et al., 2009; Shriner et al., 2010] or a weighted combination panel
[Egyud et al., 2009; Huang et al., 2009; Pasaniuc et al., 2010; Pemberton et al., 2008].
The cosmopolitan panel may include haplotypes from populations that are irrelevant,
and fails to reflect the underlying ancestry proportions and consequently the LD pattern
for the target population. The weighted combination panel is generated by duplicating
haplotypes according to certain weights, which substantially and unnecessarily increases
computational costs [Egyud et al., 2009].
An alternative approach, based on identity-by-state (IBS) sharing between the target
individual and haplotypes in the reference populations, can be embedded within exist-
ing imputation models. This approach constructs individual-specific effective reference
panels, by selecting the most closely related haplotypes (according to IBS score) from
the entire reference pool. The IBS-based selection is intuitive and useful for reducing
the size of the effective reference panel and is tailored separately for each target individ-
ual. The selection is usually conducted by finding pairwise Hamming distances which is
computationally very appealing. A simple IBS-based method, which selects a subset of
haplotypes into the effective reference panel according to their Hamming distance with
the haplotypes to be inferred across the entire genomic region to be imputed (hereafter
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referred to as whole-haplotype), has been adopted by IMPUTE2 [Howie et al., 2009].
Although some promising results have been shown when compared with random selec-
tion, no work has examined alternatives to this simple whole-haplotype based matching,
partly due to the heavy computational burden posed.
In this chapter, I evaluated two classes of reference selection methods: IBS-based
and ancestry-weighted approaches. Among the IBS-based approaches, I propose a novel
method based on IBS matching in a piecewise manner. The method breaks genomic
region under investigation into small pieces and finds reference haplotypes that best
represent every small piece, for each target individual separately. The method can be
incorporated directly into existing imputation algorithms and has identical computational
complexity to that of the existing whole-haplotype IBS-based method. Results from
all real datasets evaluated suggest that my piecewise IBS method is highly robust and
stable even when a small number of reference haplotypes are selected. Importantly,
for uncommon variants, my piecewise IBS selection method manifests more pronounced
advantage with large reference panels.
I have implemented all methods evaluated, including my piecewise IBS selection
method, in the software package MaCH-Admix. Besides the new reference selection
functionality, my software also retains high flexibility in two major aspects. First, both
regional and whole-chromosome imputation can be accommodated. Second, both data
independent and data dependent model parameter estimation are supported. Thus, be-
sides standard reference panel with pre-calibrated parameters, I can elegantly handle
study-specific reference panels and target samples with unknown ethnic origin.
The rest of the chapter is organized as follows. I first present the general framework
of the imputation algorithm, followed by the intuition and formulation of my piecewise
IBS and various other effective reference selection methods. Then I evaluate all these
methods implemented in MaCH-Admix, the whole-haplotype IBS method implemented
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in IMPUTE2 [Howie et al., 2009], and BEAGLE[Browning and Browning, 2009] using
the following datasets:
• 3587 Hispanic American individuals from the Women’s Health Initiative (WHI)
• 8421 African American individuals from the WHI
• 49 HapMap III African American individuals
• 50 HapMap III Mexican individuals
All datasets are imputed with reference from the 1000 Genomes Project (2188 haplo-
types). I also explored the performance with small/medium reference set from HapMap
II/III. Finally, I provide practical guidelines for imputation in admixed populations in
the Discussion section.
4.2 Materials and Methods
Assume that we have n individuals in the target population that are genotyped at a
set of markers denoted by Mg. In addition, we have an independent set of H reference
haplotypes, e.g., those from the International HapMap or the 1000 Genomes Projects,
encompassing a set of markers denoted by Mr . Without loss of generality, I assume that
the set of markers assayed in the target population, Mg, is a subset ofMr, the markers in
the reference population. The goal of genotype imputation is to fill in missing genotypes
including those missing by design (for example, genotypes at markers in Mr but not Mg,
commonly referred to as untyped markers). As described earlier [Li et al., 2010a], the hid-
den Markov model as implemented in MaCH fulfills the goal by inferring the haplotypes
encompassing Mr markers for each target individual, from unphased genotypes at the
directly assayed markers in Mg. Haplotype reconstruction is accomplished by building
imperfect mosaics using some of the H reference haplotypes.
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4.2.1 General Framework
Since admixed individuals have inherited genetic information from more than one ances-
tral population, I start with a pooled panel: a panel with haplotypes from all relevant
populations, for example, CEU+YRI for African Americans and CEU+YRI+JPT+CHB
for Hispanic Americans, where CEU is an abbreviation for Utah residents (CEPH)
with Northern and Western European ancestry; YRI for Yoruba in Ibadan, Nigeria;
JPT for Japanese in Tokyo, Japan; and CHB for Han Chinese in Beijing, China. Let
G = (g1, g2, g3, ..., gMr) denote the unphased genotypes at Mr markers for a target in-
dividual. Furthermore I define a series of variables Sm, m = 1, 2, ...,Mr to denote the
hidden state underlying each unphased genotype gm. The hidden state Sm consists of
an ordered pair of indices (xm, ym) indicating that, at marker m, the first chromosome
of this particular target individual uses reference haplotype xm as the template and the
second chromosome uses reference haplotype ym as the template, where xm and ym both
take values from {1, 2, ..., H}.
I seek to infer the posterior probabilities of the sequence of hidden states S =
(S1, S2, ..., SMr) for each individual as the knowledge of S will determine genotype at
each of the Mr markers. Define P (Sm|H,G) as the posterior probability for Sm, the hid-
den state at marker m with H denoting the pool of reference haplotypes and G denoting
the genotype vector of the target individual. To infer these posterior probabilities, I run
multiple Markov iterations. Within each iteration, I calculate the conditional joint prob-
abilities P (Sm,G|H) at each marker m via an adapted Baum’s forward and backward
algorithm as previously described [Li et al., 2010a].
For admixed populations, as one tends to include more reference haplotypes in the
pool under the philosophy of erring on the safe side, and as one attempts not to duplicate
haplotypes, one key aspect of the modeling is on how to traverse the sample space
harboring the most probability mass with minimum computational efforts.
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4.2.2 Piecewise IBS-based Reference Selection
In piecewise IBS selection, I seek to construct a set of t effective reference haplotypes
from the pool of H haplotypes within each HMM iteration for each target individual
separately. Selected reference panels are therefore tailored for each target individual.
For presentation clarity, I consider a single target individual. Specifically, I calculate the
genetic similarity (measured by IBS, the Hamming distance between two haplotypes) in
a piecewise manner between the individual and each haplotype in the reference pool,
ignoring the sub-populations (e.g., CEU or YRI) within the reference.
Denote (h′1,h
′
2) as the current haplotype guess for the target individual. I break
haplotype h′1 into a maximum of
t
2
pieces so that the typed markers are evenly placed
across pieces. Each piece has a minimum length of ν typed markers to ensure that the
calculated Hamming distance is informative. Denote the number of pieces by p. For each
haplotype piece, I calculated the piece-specific IBS score between h′1 and each reference
haplotype and selects the top t
2p
reference haplotypes, resulting in a total of t
2
selected
for h′1 across all p regions. I repeat the same procedure for h
′
2 and select a second set of
t
2
reference haplotypes. In my implementation, I set ν = 32, which corresponds to an av-
erage length of <200Kb for commonly used genomewide genotyping platforms. To avoid
creating spurious recombinations at piece boundary, I apply a random offset to the first
piece in each sampling so that the boundaries differ across iterations. In the case where
t
2p
is not an integer, I select ( t
2p
) (the ceiling integer) reference haplotypes in each piece
for each target haplotype. Then I sample randomly from the selected reference haplo-
types. Note that the piecewise selection is repeated for each individual in each sampling
iteration. Thus the selection will change along with the intermediate sampling results.
I have also implemented two whole-haplotype IBS-based methods, IBS Single Queue
(IBS-SQ) and IBS Double Queue (IBS-DQ). The former defines IBS score with any
reference haplotype as the minimum Hamming distance to h′1 and h
′
2, thus ordering
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the H reference haplotypes in a single queue. The top t reference haplotypes will be
selected accordingly. The latter defines two separate IBS scores for h′1 and h
′
2, thus
ordering the H reference haplotypes in two queues. The top t/2 reference haplotypes
will be selected for h′1 according to IBS scores for h
′
1. Similarly, another t/2 reference
haplotypes will be selected for h′2.
Figure 4.1 explains the three IBS strategies under two simple scenarios. In both
scenarios, there are eight markers measured in both target and reference with color
indicating the allelic status where the same color at the same locus implies the same
allele. In both Figures 4.1A and 4.1B, the first chromosome of the target individual
shares all eight alleles with the dark-colored reference haplotypes and zero alleles with
the light-shaded reference haplotypes. In Figure 4.1A, the second chromosome of the
target individual shares two alleles with the dark-colored reference haplotypes and the
remaining six alleles with the light-shaded reference haplotypes; whereas in Figure 4.1B,
the second chromosome shares six alleles with the dark-colored reference haplotypes and
the remaining two alleles with the light-shaded reference haplotypes.
Suppose t = H
2
. Figure 4.1A illustrates a scenario where the whole-haplotype Single
Queue strategy is not optimal because only dark-colored haplotypes will be selected into
the effective reference panel. By combining two sets selected from two separate queues,
the whole-haplotype Double Queue strategy is advantageous in the scenario. On the other
hand, neither the whole-haplotype Single Queue nor the whole-haplotype Double Queue
strategy can handle the scenario in Figure 4.1B well because both strategies would only
select the dark-colored reference haplotypes. Ideally, the selected reference haplotypes
should, when possible, contain information to represent every part of both chromosomes
carried by the target individual. In the scenario presented in Figure 4.1B, because the
target individual carries segment of the light-shaded haplotype, it is desirable to have
some representation of the light-shaded haplotypes in the effective reference panel. My
piecewise IBS method achieves this by breaking the whole region into pieces and selecting
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some reference haplotypes according to genetic matching in each piece (illustrated in the
bottom part of Figure 4.1A and 4.1B). By conducting local IBS-matching and choosing
a few reference haplotypes within each piece, it is able to have some representation of the
light-shaded reference haplotypes. As a result, all parts of the target chromosomes are
well represented by the selected reference haplotypes. In general, I believe that selecting a
small number of reference haplotypes for each piece locally performs better than selecting
globally at the whole-haplotype level. Note that the piecewise IBS method has the same
computational complexity as the two whole-haplotype IBS methods.
A B
Break into pieces to conduct IBS matching Break into pieces to conduct IBS matching
Figure 4.1: A cartoon illustration of two scenarios where three IBS-based selection meth-
ods perform differently. The two lines on the top panel represent the two chromosomes of
a target individual and the lines on the bottom panel represent the pool of H=16 reference
haplotypes. Color determines the allelic status such that the same color at the same locus
implies the same allele. The bottom parts show how my piecewise selection method breaks
the imputation region into four pieces with t = H2 = 8. Here I assume no constraint on the
minimum piece size (i.e., ν = 0).
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4.2.3 Ancestry-weighted Approach
Besides IBS-based methods, I also evaluate an ancestry-weighted selection method, which
is motivated by the idea of weighted cosmopolitan panel discussed in the Introduction
Section. This method concerns the scenario where the reference panel consists of hap-
lotypes from several populations, for instance CEU and YRI, such that the H reference
haplotypes are naturally decomposed into several groups. Let Q denote the number of
populations included and Hq denote the number of haplotypes from reference population
q, q = 1, 2, ..., Q. I first consider the issue of weight determination for each contributing
reference population, i.e., the fraction of reference haplotypes to be selected from that
population. Intuitively, the weights should depend on the proportions of ancestry from
these reference populations for the target admixed individual(s). The weights can be, on
one extreme, the same for all individuals in the target population (for example, when
the admixture makeup is similar across all individuals), or different for sub-populations
within the target population, or on the other extreme, specific for each target individual.
For presentation clarity, I suppress the individual index i and denote w = (w1, w2, ..., wQ)
as the vector of weights, under the constraint that w1 + w2 + ...+ wQ = 1. In this work,
I consider the same set of weights for all target individuals. The weights are to represent
the average contributions over the imputation region and for all target individuals. I
choose to use such average weights over weights specific to each single individual because
the average weights can be more stably estimated.
There are several natural ways to estimate the weights. One could pre-specify the
weights according to estimates of ancestry proportion. For example, it is reasonable to
use a ∼2:8 CEU:YRI weighting scheme for African Americans who are estimated to have
about 20% Caucasian and 80% African ancestries [Lind et al., 2007; Parra et al., 1998;
Reiner et al., 2007; Steﬄova et al., 2011]. Alternatively, one can estimate the ances-
try proportions for the target individuals under investigation. I have implemented an
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imputation-based approach within MaCH-Admix to infer ancestry proportions, accord-
ing to the contributions of reference haplotypes from each population to the constructed
mosaics of the target individuals so that the weights can be estimated by MaCH-Admix
internally. I use the software package structure [Pritchard et al., 2000], specifically
its Admix+LocPrior model, on LD-pruned set of SNPs to confirm my internal ances-
try inference.
Having determined the weights, I am interested in constructing a set of t effective ref-
erence haplotypes within each Markov iteration from the pool of H reference haplotypes
according to the ancestry proportions. I achieve this by sampling without replacement
t × wq haplotypes from the Hq haplotypes in reference population q. For each target
individual, I sample a different reference panel under the same set of weights.
4.2.4 MaCH-Admix
I have implemented the aforementioned methods (three IBS-based and one ancestry-
weighted) in my software package MaCH-Admix. MaCH-Admix breaks the one-step
imputation in MaCH into three steps: phasing, model parameter (including error rate
and recombination rate parameters) estimation and haplotype-based imputation. The
splitting into phasing and haplotype-based imputation is similar to IMPUTE2. My
software can accommodate both regional and whole-chromosome imputation and allows
both data dependent and data independent model parameter estimation. The flexibility
regarding model parameter estimation allows one to perform imputation with standard
reference panels such as those from the HapMap or the 1000 Genomes Projects with pre-
calibrated parameters in a data independent fashion, similar to IMPUTE2, which uses
recombination rates estimated from the HapMap data and a constant mutation rate.
Alternatively, if one works with study-specific reference panels, or suspects the model
parameters differ from those pre-calibrated (for example, when target individuals are of
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unknown ethnicity or from an isolated population), one has the option to simultaneously
estimate these model parameters while performing imputation.
4.2.5 Datasets
I assessed the reference selection methods in the following six target sets:
• 3587 WHI Hispanic Americans (WHI-HA)
• 8421 WHI African Americans (WHI-AA)
• 200 randomly sampled WHI-HA individuals
• 200 randomly sampled WHI-AA individuals
• 49 HapMap III African Americans (ASW)
• 50 HapMap III Mexican individuals (MEX)
The WHI SHARe consortium offers one of the largest genetic studies in admixed
populations. WHI [The WHI Study Group, 1998; Anderson et al., 2003] recruited a to-
tal of 161, 808 women with 17% from minority groups (mostly African Americans and
Hispanics) from 1993-1998 at 40 clinical centers across the U.S. The WHI SHARe con-
sortium genotyped all the WHI-AA and WHI-HA individuals using the Affymetrix 6.0
platform. Detailed demographic and recruitment information of these genotyped samples
are previously described [Qayyum et al., 2012]. Besides standard quality control (details
described previously in [Liu et al., 2012]), I removed SNPs with minor allele frequency
(MAF) below 0.5%. To evaluate the imputation performance on target sets of smaller
size, I randomly sampled 200 individuals from WHI-HA and WHI-AA separately.
For the two HapMapIII datasets, my target individuals are ASW (individuals of
African ancestry in Southwest USA) and MEX (individuals of Mexican ancestry in Los
Angeles, California) respectively from the phase III of the International HapMap Project
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[The International HapMap Consortium, 2010]. These individuals (83 ASW and 77 MEX)
were all genotyped using two platforms: the Illumina Human1M and the Affymetrix 6.0.
I restricted my analysis to founders only: 49 ASW and 50 MEX.
The main focus of my work is imputation with large reference panel. Thus, I first
evaluated the imputation performance of all six target sets with reference from the 1000
Genomes Project (release 20101123, H = 2188 haplotypes). For the WHI datasets, the
number of markers overlapping between the target and reference, bounded by the number
of markers typed in target samples, is smaller than that in the HapMap individuals.
Therefore, I performed imputation 10 times, each time masking a different 5% of the
Affymetrix 6.0 markers. This masking strategy allowed us to evaluate imputation quality
at 50% of Affymetrix 6.0 SNPs. For HapMap III ASW and MEX individuals, I randomly
masked 50% of the overlapping markers and evaluated the performance at these markers.
I used two different masking schemes for the HapMap and WHI samples because I have
∼1.5 million typed markers in the HapMap samples and thus can still achieve reasonable
imputation accuracy by masking 50% of the markers in a single trial. In the WHI samples,
masking 50% of the ∼0.8 million markers in a single trial would substantially reduce
imputation accuracy and using one trial with a small percentage of markers masked
would lead to insufficient number of markers for evaluation. Therefore, I used multiple
trials with 5% masking for the WHI datasets.
To provide a comprehensive evaluation, I also conducted imputation on all six tar-
get sets using HapMapII or HapMapIII haplotypes as the reference. I used HapMap II
CEU+YRI (H = 240) for WHI-AA individuals and HapMapII CEU+YRI+JPT+CHB
(H = 420) for WHI-HA individuals. The evaluation is based on masking 50% of the
overlapping markers. For HapMap III ASW target set, I considered three different refer-
ence panels: HapMapII CEU+YRI (H = 240), HapMapIII CEU+YRI (H = 464), and
HapMapIII CEU+YRI+LWK+MKK (H = 930), where LWK (Luhya in Webuye, Kenya)
and MKK (Maasai in Kinyawa, Kenya) are two African populations from Kenya. For
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HapMap III MEX target set, I considered HapMapII CEU+YRI+JPT+CHB (H = 420),
and HapMapIII CEU+YRI+JPT+CHB (H = 804). For the HapMap target sets with
HapMap references, I used genotypes at SNPs on the Illumina HumanHap650 Bead-
Chip for imputation input and reserved other genotypes for evaluation. I have posted
the HapMap data and my command lines used in this work on MaCH-Admix website
(see Web Resources).
I picked five 5Mb regions across the genome to represent a wide spectrum of LD
levels. I first calculated median half life of r2, defined as the physical distance at which
the median r2 between pairs of SNPs is 0.5, for every 5Mb region using a sliding window of
1Mb, in CEU, YRI, and JPT+CHB, respectively. I used HapMapII phased haplotypes for
the calculation. The five regions I picked are: chromosome3:80-85Mb, chromosome1:75-
80Mb, chromosome4:57-62Mb, chromosome14:50-55Mb, and chromosome8:18-23Mb in
a decreasing order of LD level. The median half life of r2 is around 90th, 70th, 50th,
30th, and 10th percentile within each of the three HapMap populations, for the five
regions respectively (Table 4.1). Figure 4.2 shows the LD levels for the five residing
chromosomes. For each region, I treat the middle 4Mb as the core region and the 500Kb
on each end as flanking regions. Only SNPs imputed in the core region were evaluated
to gauge imputation accuracy.
Table 4.1: Median Half Life of r2 (in Kb)
CEU YRI JPT+CHB
10th Percentile 26 16 22
30th Percentile 38 24 32
50th Percentile 48 30 41
70th Percentile 60 39 55
90th Percentile 92 57 83
chromosome3:80-85Mb 106 70 124
chromosome1:75-80Mb 69 38 80
chromosome4:57-62Mb 47 31 32
chromosome14:50-55Mb 40 25 43
chromosome8:18-23Mb 25 16 23
Percentiles are calculated within each population using all 5Mb windows across the genome.
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Figure 4.2: Median r2 half-life value of 5Mb windows on 5 chromosomes
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4.2.6 Methods Compared
I evaluated the following reference selection approaches implemented in MaCH-Admix:
• random selection (MaCH-Admix Random or original MaCH)
• IBS Piecewise selection (MaCH-Admix IBS-PW)
• IBS Single-Queue selection (MaCH-Admix IBS-SQ)
• IBS Double-Queue selection (MaCH-Admix IBS-DQ)
• Ancestry-Weighted selection (MaCH-Admix AW) (for HapMapIII datasets)
I also included IMPUTE2 [Howie et al., 2009] and BEAGLE [Browning and Brown-
ing, 2009] for comparison. I used IMPUTE 2.1.2 and BEAGLE 3.3.1 with default set-
tings (-k hap 500 -iter 30 for IMPUTE2; niterations=10 nsamples=4 for BEAGLE). As
aforementioned, MaCH-Admix can conduct imputation with pre-calibrated parameters
(similar to IMPUTE2); alternatively, MaCH-Admix can perform imputation together
with data-dependent parameter estimation in an integrated mode. The integrated mode
generates slightly better results at the cost of increased computing time. Here, I report
results from the pre-calibrated mode.
4.2.7 Measure of Imputation Quality
Previous studies have proposed multiple statistics to measure imputation quality [Brown-
ing and Browning, 2009; Li et al., 2009; Lin et al., 2010; Marchini and Howie, 2010],
measuring either the concordance rate, correlation, or agreement between the imputed
genotypes or estimated allele dosages (the fractional counts of an arbitrary allele at each
SNP for each individual, ranging continuously from 0 to 2) and their experimental coun-
terpart. I opt to report the dosage r2 values, which are the squared Pearson correlation
between the estimated allele dosages and the true experimental genotypes (recoded as 0,
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1, and 2 corresponding to the number of minor alleles), because it is a better measure for
uncommon variants by taking allele frequency into account and directly related to the ef-
fective sample size for downstream association analysis (Pritchard and Przeworski, 2001).
For the remainder of the work, with no special note, average dosage r2 values will be plot-
ted as a function of approximation level (measured by the effective reference panel size,
i.e., t described in Methods section, corresponding to MaCH-Admix’s --states option and
IMPUTE2’s -k option). Hereafter, I use approximation level, effective reference size, t,
and #states/-k interchangeably. I note that for standard haplotypes-to-genotype impu-
tation (that is, using reference haplotypes to imputed target individuals with genotypes),
computational costs increase quadratically with the approximation level. MaCH-Admix
and IMPUTE2 both also have an approximation parameter at the haplotype-based im-
putation step, MaCH-Admix’s --imputeStates and IMPUTE2’s -k hap, which increases
the computation time linearly and is by default set at a large value (500). I kept both at
the default value because increasing beyond the default has rather negligible effects on
imputation quality and that total computing time attributable to the haplotype-based
imputation step is typically much smaller compared to --states and -k.
4.3 Results
4.3.1 WHI-AA and WHI-HA with the 1000G Reference
Figures 4.3 and 4.4 show results for full WHI-HA andWHI-AA sets using 2188 haplotypes
from 20101123 release of the 1000 Genomes Project as the reference (selected three out
of the five 5Mb regions: the 1st, 3rd, and 5th regions according to level of LD). The
remaining results under the default or middle settings are presented in Tables 4.2 and
4.3 (all five regions for WHI-HA and WHI-AA respectively). Note that BEAGLE’s
performance remains constant because it does not have a parameter analogous to MaCH-
Admix’s --states or IMPUTE2’s -k.
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Generally, I observe higher imputation accuracy in regions with higher level of LD for
all approaches evaluated. In addition, in regions with higher LD, imputation accuracy
reaches a plateau with smaller effective reference sizes. This is because the LD pattern
can be captured fairly well by a smaller number of reference haplotypes in regions with
higher level of LD. In regions with lower level of LD, accuracy plateau is reached with
larger effective reference sizes. But generally an effective reference size of 80 to 120 is
good for MaCH-Admix to perform well at all LD levels.
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B: Uncommon SNP imputation quality of WHI-HA with the 1000G reference panel. I set the maximum plotting range on y-axis to
be 5%. IMPUTE2 in (c) is below the lower bound of the plotting range.
Figure 4.3: Imputation of 3587 WHI-HA with the 1000G reference panel. Imputation quality (measured by dosage r2) is plotted
as a function of the effective reference panel size (i.e., #states), for WHI-HA individuals in three selected 5Mb regions (ordered by
LD from high to low).
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B: Uncommon SNP imputation quality of WHI-AA with the 1000G reference panel. Note that WHI-AA has significantly less number
of SNPs in this category than WHI-HA does. Also, I set the maximum plotting range on y-axis to be 5%. MaCH-Admix Random
in (b),(c) and BEAGLE in (a),(b),(c) are below the lower bound of the plotting range.
Figure 4.4: Imputation of 8421 WHI-AA with the 1000G reference panel. Imputation quality (measured by dosage r2) is plotted
as a function of the effective reference panel size (i.e., #states), for WHI-AA individuals in three selected 5Mb regions (ordered by
LD from high to low).
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I found that the piecewise IBS selection approach (IBS-PW) is clearly the best among
the three IBS-based methods implemented in MaCH-Admix. Its performance is stable
even with a small #states value. For the other two IBS-based reference selection ap-
proaches implemented in MaCH-Admix, I observed IBS-DQ performs better than IBS-
SQ. The performance order of the three MaCH-Admix IBS-based methods is expected
based on my reasoning in the Material and Methods Section. In addition, all three
IBS-based methods show clear advantage over random selection, particularly when the
effective reference size is small. IMPUTE2 has similar performance to that of IBS-DQ
when the effective reference size is small. Interestingly, IMPUTE2’s accuracy curve tends
to stay relatively flat while those for MaCH-Admix’s IBS-based methods increase with
the effective reference size.
Across all five regions evaluated, with effective reference size at 120, IBS-PW has
consistent performance gain over other evaluated methods. Importantly, IBS-PW and
IBS-DQ, particularly IBS-PW, manifest more pronounced advantage for uncommon vari-
ants (MAF <5%) in WHI-HA. For these uncommon variants, average dosage r2 is 0.818,
0.782, and 0.794 (0.808, 0.805, and 0.756) for WHI-HA (WHI-AA) using IBS-PW, IM-
PUTE2, and BEAGLE respectively. The advantage of IBS-PW in uncommon SNPs is
however smaller in WHI-AA largely because of the much smaller number of uncommon
variants in WHI-AA (Figure 4.5). However, the difference is highly significant (p-value
≤5.02 × 10−5) in both WHI samples. My observation is consistent in both the full set
and the subset of 200 individuals (Tables 4.2 and 4.3).
The variance of imputation quality by markers is heavily influenced by the MAF
distribution. All methods exhibits much larger variance in imputing uncommon variants.
The standard error of my IBS-PW method ranges from 0.0046 to 0.0055 for all variants,
and from 0.016 to 0.0248 for uncommon variants in imputing the WHI-HA full set. In
imputing the WHI-AA full set, the standard error of IBS-PW ranges from 0.0037 to
0.0047 for all variants, and from 0.02 to 0.0299 for uncommon variants.
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Table 4.2: Imputation Results of WHI-HA Individuals over Five 5Mb Regions with the
1000G reference
All 3587 individuals Random 200 Subset
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.935(0.107) 0.796(0.189) 35968 0.921(0.121) 0.794(0.231) 841
MaCH-Admix IBS-PW 0.942(0.101) 0.817(0.189) 40422 0.923(0.111) 0.814(0.210) 1041
MaCH-Admix IBS-SQ 0.939(0.104) 0.799(0.190) 38208 0.923(0.119) 0.796(0.231) 988
MaCH-Admix IBS-DQ 0.941(0.102) 0.806(0.191) 38439 0.924(0.119) 0.799(0.232) 995
IMPUTE2 0.939(0.104) 0.797(0.191) 40722 0.925(0.119) 0.799(0.233) 2076
BEAGLE 0.931(0.107) 0.799(0.190) 162888 0.912(0.128) 0.779(0.231) 6614
chromosome1:75-80Mb
MaCH-Admix Random 0.918(0.130) 0.821(0.190) 50108 0.924(0.129) 0.855(0.211) 1214
MaCH-Admix IBS-PW 0.927(0.123) 0.841(0.186) 57671 0.927(0.121) 0.873(0.197) 1490
MaCH-Admix IBS-SQ 0.923(0.122) 0.823(0.187) 53908 0.926(0.125) 0.861(0.209) 1443
MaCH-Admix IBS-DQ 0.926(0.121) 0.830(0.185) 57321 0.928(0.123) 0.866(0.207) 1452
IMPUTE2 0.921(0.121) 0.809(0.183) 51362 0.921(0.127) 0.845(0.204) 2545
BEAGLE 0.917(0.124) 0.815(0.184) 229514 0.917(0.129) 0.851(0.209) 9194
chromosome4:57-62Mb
MaCH-Admix Random 0.904(0.148) 0.761(0.208) 53960 0.918(0.137) 0.813(0.213) 1239
MaCH-Admix IBS-PW 0.913(0.139) 0.783(0.202) 61827 0.922(0.134) 0.824(0.212) 1527
MaCH-Admix IBS-SQ 0.907(0.141) 0.757(0.195) 60806 0.918(0.135) 0.807(0.209) 1460
MaCH-Admix IBS-DQ 0.911(0.138) 0.770(0.195) 59088 0.921(0.133) 0.817(0.210) 1455
IMPUTE2 0.906(0.142) 0.751(0.198) 62272 0.908(0.147) 0.773(0.225) 2991
BEAGLE 0.900(0.150) 0.751(0.218) 360545 0.907(0.155) 0.787(0.244) 14888
chromosome14:50-55Mb
MaCH-Admix Random 0.921(0.132) 0.800(0.202) 57082 0.936(0.122) 0.847(0.202) 1600
MaCH-Admix IBS-PW 0.932(0.120) 0.826(0.184) 60800 0.940(0.119) 0.859(0.198) 1876
MaCH-Admix IBS-SQ 0.927(0.118) 0.807(0.175) 61112 0.938(0.119) 0.849(0.199) 1877
MaCH-Admix IBS-DQ 0.930(0.115) 0.819(0.176) 61175 0.939(0.118) 0.854(0.197) 1876
IMPUTE2 0.924(0.120) 0.793(0.180) 52818 0.931(0.125) 0.828(0.216) 2579
BEAGLE 0.926(0.121) 0.806(0.189) 332586 0.929(0.130) 0.824(0.218) 14182
chromosome8:18-23Mb
MaCH-Admix Random 0.896(0.155) 0.793(0.212) 75511 0.901(0.150) 0.821(0.225) 1899
MaCH-Admix IBS-PW 0.911(0.143) 0.824(0.198) 84885 0.906(0.147) 0.833(0.221) 2302
MaCH-Admix IBS-SQ 0.903(0.145) 0.797(0.200) 83051 0.903(0.149) 0.820(0.227) 2270
MaCH-Admix IBS-DQ 0.906(0.143) 0.805(0.200) 80794 0.904(0.147) 0.822(0.224) 2285
IMPUTE2 0.900(0.145) 0.773(0.206) 75001 0.893(0.159) 0.781(0.247) 3647
BEAGLE 0.905(0.142) 0.807(0.201) 498822 0.894(0.154) 0.800(0.232) 17146
All results were generated using default or suggested parameter values: MaCH-Admix:
--rounds 30, --states 120, --imputeStates 500; IMPUTE2: -iter 30, -k 120, -k hap 500;
BEAGLE: niterations=10 nsamples=4. Running time is measured in seconds.
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Table 4.3: Imputation Results of WHI-AA Individuals over Five 5Mb Regions with the
1000G reference
All 8421 Individuals Random 200 Subset
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.912(0.100) 0.782(0.150) 161637 0.932(0.091) 0.824(0.194) 897
MaCH-Admix IBS-PW 0.947(0.073) 0.850(0.158) 174083 0.945(0.083) 0.849(0.194) 1026
MaCH-Admix IBS-SQ 0.944(0.075) 0.844(0.161) 176147 0.942(0.086) 0.835(0.198) 1035
MaCH-Admix IBS-DQ 0.946(0.074) 0.849(0.160) 169442 0.944(0.083) 0.851(0.198) 1021
IMPUTE2 0.943(0.075) 0.847(0.151) 111307 0.943(0.085) 0.836(0.187) 2017
BEAGLE 0.921(0.088) 0.795(0.170) 23082∗ 0.915(0.107) 0.784(0.217) 6435
chromosome1:75-80Mb
MaCH-Admix Random 0.873(0.143) 0.703(0.219) 214385 0.886(0.141) 0.726(0.241) 1240
MaCH-Admix IBS-PW 0.921(0.106) 0.802(0.176) 226019 0.906(0.128) 0.770(0.232) 1530
MaCH-Admix IBS-SQ 0.915(0.109) 0.794(0.174) 232880 0.900(0.130) 0.756(0.224) 1504
MaCH-Admix IBS-DQ 0.918(0.106) 0.803(0.168) 232858 0.903(0.131) 0.762(0.235) 1476
IMPUTE2 0.917(0.103) 0.810(0.157) 138080 0.898(0.135) 0.760(0.240) 2412
BEAGLE 0.892(0.119) 0.759(0.173) 25618∗ 0.875(0.145) 0.713(0.242) 8621
chromosome4:57-62Mb
MaCH-Admix Random 0.883(0.126) 0.688(0.187) 241045 0.905(0.111) 0.749(0.169) 1290
MaCH-Admix IBS-PW 0.927(0.092) 0.795(0.159) 260231 0.922(0.100) 0.792(0.175) 1508
MaCH-Admix IBS-SQ 0.920(0.094) 0.782(0.148) 254002 0.915(0.105) 0.777(0.180) 1545
MaCH-Admix IBS-DQ 0.924(0.090) 0.796(0.138) 248524 0.920(0.100) 0.793(0.175) 1478
IMPUTE2 0.918(0.091) 0.787(0.129) 166642 0.912(0.104) 0.778(0.168) 2939
BEAGLE 0.898(0.109) 0.735(0.167) 43573∗ 0.892(0.131) 0.738(0.222) 14528
chromosome14:50-55Mb
MaCH-Admix Random 0.875(0.140) 0.726(0.216) 240789 0.908(0.120) 0.807(0.198) 1663
MaCH-Admix IBS-PW 0.921(0.105) 0.823(0.171) 254530 0.927(0.104) 0.852(0.167) 1900
MaCH-Admix IBS-SQ 0.914(0.108) 0.809(0.172) 253231 0.919(0.112) 0.835(0.191) 1918
MaCH-Admix IBS-DQ 0.918(0.105) 0.818(0.168) 254555 0.924(0.107) 0.850(0.175) 1900
IMPUTE2 0.912(0.106) 0.815(0.157) 143772 0.913(0.116) 0.820(0.186) 2575
BEAGLE 0.893(0.118) 0.775(0.176) 27666∗ 0.899(0.127) 0.786(0.216) 14139
chromosome8:18-23Mb
MaCH-Admix Random 0.830(0.177) 0.682(0.235) 343104 0.857(0.163) 0.735(0.235) 1977
MaCH-Admix IBS-PW 0.889(0.142) 0.798(0.207) 357858 0.884(0.148) 0.800(0.218) 2377
MaCH-Admix IBS-SQ 0.882(0.145) 0.789(0.207) 347473 0.877(0.152) 0.786(0.224) 2393
MaCH-Admix IBS-DQ 0.885(0.144) 0.795(0.205) 356928 0.881(0.149) 0.797(0.220) 2318
IMPUTE2 0.884(0.140) 0.795(0.194) 211879 0.876(0.153) 0.795(0.218) 3618
BEAGLE 0.858(0.151) 0.743(0.206) 43068∗ 0.856(0.158) 0.767(0.229) 16931
∗ In my experiments, BEAGLE cannot finish imputation with the complete 1000G
references within 7 days which is the hard limit on my cluster server. I thus restrict the
markers in the reference panel to be the set of Affymetrix 6.0 markers plus 2.5% of the
remaining 1000G markers. The size of the restricted set in each region is about 10 ∼ 15%
of the size of original 1000G marker set.
All results were generated using default or suggested parameter values: MaCH-Admix:
--rounds 30, --states 120, --imputeStates 500; IMPUTE2: -iter 30, -k 120, -k hap 500;
BEAGLE: niterations=10 nsamples=4. Running time is measured in seconds.
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Figure 4.5: Minor Allele Frequency (MAF) distribution of SNPs in WHI-AA and WHI-
HA.
4.3.2 HapMap ASW and MEX with the 1000G Reference
In this setting, I use a large reference panel to impute two small target sets. Figure 4.6
shows the imputation quality of three regions for both ASW and MEX. The complete
results are presented in Table 4.4. Similar to previous experiments, I found that IBS-PW
is very effective in finding the most relevant reference from a large panel (1000G) and
clearly outperforms the other methods. IMPUTE2 again shows a flatter curve in most
regions. Random selection and BEAGLE tend to perform worse than the IBS-based
methods. This again proves that IBS-based selections are very effective in working with
large reference panels.
In imputing ASW individuals, the standard error of my IBS-PW method ranges from
0.0034 to 0.0041 for all variants, and from 0.0189 to 0.0276 for uncommon variants. In
imputing MEX individuals, the standard error of IBS-PW ranges from 0.0031 to 0.0043
for all variants, and from 0.0132 to 0.0211 for uncommon variants.
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A: Overall imputation quality of HapMap ASW with the 1000G reference panel
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B: Overall imputation quality of HapMap MEX with the 1000G reference panel
Figure 4.6: Imputation of 49 HapMap ASW and 50 HapMap MEX individuals with the 1000G reference panel. Imputation quality
(measured by dosage r2) is plotted as a function of the effective reference panel size (i.e., #states), for WHI-AA individuals in three
selected 5Mb regions (ordered by LD from high to low).
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4.3.3 Imputation Performance with HapMap References
First, consistent with what has been reported that imputation quality improves with ref-
erence panel size, imputation quality is indeed lower with HapMap references than with
the 1000G reference. For example, average dosage r2 is 90.0-91.3% with the 1000G refer-
ence (Table 4.2) for WHI-HA individuals in the chromosome4:57-62Mb region but drops
to 84.4-86.2% with HapMapII references (Table 4.5). Second, difference among various
methods is much smaller with these smaller HapMap reference sets (H = 240 ∼ 930),
which is consistent with my intuition that, given fixed computational costs, reference
selection makes more pronounced difference with large reference panel since only a small
portion of reference can be selected.
4.3.3.1 WHI-HA and WHI-AA with HapMap references
The complete results are presented in Tables 4.5 and 4.6. In WHI-HA (Table 4.5, H =
420), IBS-PW outperforms IBS-SQ and IBS-DQ slightly and the advantage disappears in
WHI-AA (Table 4.6, H = 240). MaCH-Admix and IMPUTE2 yield similar imputation
accuracy, and both outperform BEAGLE slightly.
4.3.3.2 HapMap ASW and MEX with HapMap references
For ASW, I experimented with three reference panels: HapMapII CEU+YRI, HapMapIII
CEU+YRI, and HapMapIII CEU+YRI+LWK+MKK; for MEX two reference panels:
HapMapII CEU+YRI+JPT+CHB and HapMapIII CEU+YRI+JPT+CHB. Results for
ASW with HapMapIII CEU+YRI+LWK+MKK as the reference are shown in Figure 4.7
(the same three selected regions). The remaining results are presented in Tables 4.7, 4.8
and 4.9. Again, MaCH-Admix and IMPUTE2 yield similar imputation accuracy, both
outperform BEAGLE slightly. IBS-PW is still an obvious winner in most regions and
settings. But the relative difference among different methods diminishes when H is small.
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Table 4.4: Imputation Results of HapMap ASW & MEX Individuals over Five 5Mb
Regions with the 1000G reference (H = 2188)
49 ASW Individuals 50 MEX Individuals
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.937(0.104) 0.854(0.210) 189 0.966(0.080) 0.960(0.149) 173
MaCH-Admix IBS-PW 0.948(0.095) 0.888(0.192) 252 0.968(0.077) 0.968(0.148) 212
MaCH-Admix IBS-SQ 0.948(0.091) 0.898(0.176) 220 0.967(0.079) 0.961(0.148) 203
MaCH-Admix IBS-DQ 0.947(0.095) 0.889(0.190) 220 0.967(0.079) 0.963(0.149) 221
IMPUTE2 0.942(0.106) 0.877(0.201) 457 0.968(0.086) 0.953(0.187) 477
BEAGLE 0.906(0.137) 0.774(0.267) 2388 0.960(0.096) 0.938(0.196) 2760
chromosome1:75-80Mb
MaCH-Admix Random 0.915(0.135) 0.828(0.233) 273 0.937(0.132) 0.854(0.238) 257
MaCH-Admix IBS-PW 0.930(0.123) 0.859(0.216) 329 0.940(0.134) 0.867(0.250) 302
MaCH-Admix IBS-SQ 0.926(0.128) 0.849(0.222) 331 0.938(0.130) 0.870(0.235) 293
MaCH-Admix IBS-DQ 0.928(0.127) 0.852(0.227) 330 0.938(0.132) 0.866(0.243) 299
IMPUTE2 0.915(0.140) 0.842(0.229) 609 0.933(0.140) 0.847(0.270) 549
BEAGLE 0.900(0.148) 0.817(0.245) 3195 0.931(0.144) 0.839(0.264) 3779
chromosome4:57-62Mb
MaCH-Admix Random 0.922(0.116) 0.801(0.230) 283 0.941(0.127) 0.873(0.228) 244
MaCH-Admix IBS-PW 0.937(0.107) 0.852(0.220) 325 0.945(0.118) 0.896(0.203) 298
MaCH-Admix IBS-SQ 0.933(0.110) 0.837(0.224) 322 0.945(0.116) 0.894(0.200) 286
MaCH-Admix IBS-DQ 0.934(0.107) 0.845(0.215) 325 0.944(0.119) 0.883(0.210) 290
IMPUTE2 0.927(0.116) 0.819(0.238) 743 0.943(0.120) 0.889(0.207) 785
BEAGLE 0.897(0.144) 0.755(0.284) 4364 0.931(0.143) 0.839(0.263) 5677
chromosome14:50-55Mb
MaCH-Admix Random 0.899(0.144) 0.739(0.280) 392 0.947(0.119) 0.891(0.218) 366
MaCH-Admix IBS-PW 0.914(0.134) 0.769(0.273) 438 0.951(0.118) 0.900(0.218) 420
MaCH-Admix IBS-SQ 0.909(0.138) 0.765(0.282) 419 0.948(0.120) 0.896(0.223) 420
MaCH-Admix IBS-DQ 0.909(0.135) 0.763(0.264) 438 0.947(0.122) 0.889(0.231) 429
IMPUTE2 0.901(0.145) 0.770(0.281) 636 0.940(0.126) 0.874(0.234) 562
BEAGLE 0.879(0.167) 0.677(0.325) 4868 0.939(0.128) 0.872(0.232) 4643
chromosome8:18-23Mb
MaCH-Admix Random 0.859(0.172) 0.755(0.283) 420 0.914(0.145) 0.892(0.200) 404
MaCH-Admix IBS-PW 0.879(0.162) 0.792(0.280) 523 0.921(0.140) 0.908(0.186) 487
MaCH-Admix IBS-SQ 0.872(0.164) 0.775(0.282) 537 0.916(0.145) 0.898(0.197) 485
MaCH-Admix IBS-DQ 0.874(0.166) 0.774(0.293) 526 0.918(0.143) 0.901(0.196) 495
IMPUTE2 0.865(0.173) 0.767(0.298) 818 0.902(0.164) 0.864(0.247) 854
BEAGLE 0.844(0.181) 0.760(0.285) 6295 0.906(0.156) 0.875(0.233) 6509
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120, --imputeStates 500; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE:
niterations=10 nsamples=4. Running time is measured in seconds. Best performance in
each comparison is highlighted by bold font.
76
Table 4.5: Imputation Results of WHI-HA Individuals over Five 5Mb Regions with the
HapMapII reference (H = 420)
All 3587 individuals Random 200 Subset
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.897(0.157) 0.864(0.091) 9907 0.885(0.150) 0.807(0.101) 234
MaCH-Admix IBS-PW 0.905(0.150) 0.918(0.021) 10373 0.888(0.150) 0.831(0.081) 248
MaCH-Admix IBS-SQ 0.904(0.150) 0.913(0.033) 11303 0.887(0.150) 0.838(0.088) 246
MaCH-Admix IBS-DQ 0.904(0.150) 0.911(0.036) 10434 0.888(0.147) 0.845(0.082) 247
IMPUTE2 0.904(0.148) 0.924(0.011) 8874 0.887(0.144) 0.843(0.044) 403
BEAGLE 0.892(0.159) 0.902(0.062) 11877 0.873(0.164) 0.831(0.106) 232
chromosome1:75-80Mb
MaCH-Admix Random 0.855(0.184) 0.752(0.222) 14227 0.857(0.185) 0.723(0.253) 350
MaCH-Admix IBS-PW 0.863(0.176) 0.762(0.201) 13328 0.859(0.183) 0.721(0.236) 367
MaCH-Admix IBS-SQ 0.860(0.179) 0.748(0.204) 15146 0.860(0.181) 0.715(0.234) 363
MaCH-Admix IBS-DQ 0.861(0.178) 0.750(0.204) 15878 0.858(0.183) 0.712(0.237) 377
IMPUTE2 0.842(0.188) 0.740(0.248) 11782 0.840(0.194) 0.701(0.282) 556
BEAGLE 0.851(0.186) 0.792(0.230) 15446 0.849(0.191) 0.795(0.250) 296
chromosome4:57-62Mb
MaCH-Admix Random 0.852(0.169) 0.742(0.237) 14728 0.863(0.165) 0.775(0.210) 343
MaCH-Admix IBS-PW 0.862(0.162) 0.764(0.217) 17051 0.869(0.162) 0.787(0.201) 360
MaCH-Admix IBS-SQ 0.860(0.161) 0.756(0.223) 16123 0.868(0.162) 0.779(0.211) 362
MaCH-Admix IBS-DQ 0.860(0.161) 0.757(0.224) 15364 0.867(0.164) 0.786(0.205) 363
IMPUTE2 0.844(0.176) 0.717(0.231) 12369 0.847(0.180) 0.732(0.221) 541
BEAGLE 0.850(0.168) 0.740(0.234) 17503 0.851(0.174) 0.734(0.263) 348
chromosome14:50-55Mb
MaCH-Admix Random 0.845(0.190) 0.669(0.285) 19813 0.850(0.191) 0.677(0.290) 428
MaCH-Admix IBS-PW 0.854(0.184) 0.689(0.274) 19214 0.854(0.186) 0.690(0.273) 448
MaCH-Admix IBS-SQ 0.852(0.184) 0.682(0.283) 18357 0.854(0.186) 0.678(0.289) 450
MaCH-Admix IBS-DQ 0.852(0.184) 0.686(0.278) 19201 0.855(0.186) 0.689(0.277) 453
IMPUTE2 0.856(0.183) 0.681(0.272) 14430 0.855(0.187) 0.686(0.286) 660
BEAGLE 0.846(0.186) 0.666(0.279) 17102 0.845(0.191) 0.641(0.327) 356
chromosome8:18-23Mb
MaCH-Admix Random 0.826(0.216) 0.760(0.246) 22069 0.830(0.216) 0.754(0.244) 524
MaCH-Admix IBS-PW 0.838(0.211) 0.775(0.240) 21194 0.838(0.213) 0.763(0.238) 551
MaCH-Admix IBS-SQ 0.832(0.213) 0.765(0.241) 22098 0.833(0.213) 0.758(0.242) 551
MaCH-Admix IBS-DQ 0.833(0.213) 0.768(0.241) 22360 0.833(0.216) 0.750(0.243) 553
IMPUTE2 0.839(0.207) 0.772(0.236) 17910 0.835(0.214) 0.744(0.253) 875
BEAGLE 0.826(0.211) 0.742(0.245) 27236 0.822(0.215) 0.732(0.258) 543
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120, --imputeStates 500; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE:
niterations=10 nsamples=4. Running time is measured in seconds. Best performance in
each comparison is highlighted by bold font.
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Table 4.6: Imputation Results of WHI-AA Individuals over Five 5Mb Regions with the
HapMapII reference (H = 240)
All 8421 Individuals Random 200 Subset
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.877(0.140) 0.684(0.271) 56434 0.875(0.149) 0.636(0.354) 259
MaCH-Admix IBS-PW 0.884(0.136) 0.683(0.294) 52858 0.877(0.149) 0.641(0.369) 275
MaCH-Admix IBS-SQ 0.883(0.137) 0.678(0.294) 61142 0.877(0.148) 0.645(0.356) 264
MaCH-Admix IBS-DQ 0.883(0.137) 0.677(0.297) 56255 0.876(0.150) 0.627(0.349) 265
IMPUTE2 0.885(0.135) 0.668(0.290) 25283 0.879(0.148) 0.613(0.371) 388
BEAGLE 0.842(0.164) 0.575(0.259) 116113 0.841(0.173) 0.558(0.368) 234
chromosome1:75-80Mb
MaCH-Admix Random 0.822(0.166) 0.746(0.146) 66325 0.811(0.174) 0.746(0.176) 394
MaCH-Admix IBS-PW 0.830(0.160) 0.759(0.143) 73130 0.815(0.172) 0.757(0.194) 407
MaCH-Admix IBS-SQ 0.830(0.160) 0.762(0.143) 75065 0.814(0.174) 0.746(0.200) 403
MaCH-Admix IBS-DQ 0.831(0.160) 0.764(0.144) 77968 0.815(0.173) 0.751(0.198) 402
IMPUTE2 0.812(0.167) 0.736(0.137) 35170 0.794(0.181) 0.712(0.167) 556
BEAGLE 0.798(0.185) 0.685(0.167) 142769 0.776(0.200) 0.656(0.222) 291
chromosome4:57-62Mb
MaCH-Admix Random 0.832(0.150) 0.664(0.152) 77490 0.831(0.154) 0.679(0.177) 368
MaCH-Admix IBS-PW 0.841(0.144) 0.686(0.149) 74439 0.835(0.152) 0.693(0.177) 378
MaCH-Admix IBS-SQ 0.842(0.143) 0.689(0.143) 74604 0.836(0.150) 0.704(0.169) 400
MaCH-Admix IBS-DQ 0.842(0.143) 0.691(0.142) 76374 0.835(0.152) 0.693(0.159) 384
IMPUTE2 0.826(0.153) 0.654(0.160) 34875 0.816(0.162) 0.666(0.177) 513
BEAGLE 0.798(0.183) 0.552(0.271) 145240 0.788(0.199) 0.464(0.261) 298
chromosome14:50-55Mb
MaCH-Admix Random 0.770(0.195) 0.628(0.288) 82618 0.780(0.199) 0.671(0.278) 427
MaCH-Admix IBS-PW 0.781(0.188) 0.645(0.279) 77589 0.784(0.195) 0.681(0.268) 442
MaCH-Admix IBS-SQ 0.780(0.187) 0.647(0.280) 82175 0.786(0.196) 0.679(0.262) 436
MaCH-Admix IBS-DQ 0.780(0.188) 0.644(0.283) 90951 0.787(0.194) 0.678(0.265) 450
IMPUTE2 0.791(0.180) 0.667(0.270) 39702 0.789(0.194) 0.689(0.265) 597
BEAGLE 0.742(0.210) 0.553(0.308) 124661 0.739(0.221) 0.579(0.315) 336
chromosome8:18-23Mb
MaCH-Admix Random 0.754(0.222) 0.619(0.241) 99090 0.758(0.216) 0.649(0.233) 570
MaCH-Admix IBS-PW 0.764(0.217) 0.641(0.240) 104999 0.764(0.214) 0.665(0.230) 584
MaCH-Admix IBS-SQ 0.768(0.214) 0.654(0.235) 95685 0.765(0.213) 0.677(0.232) 593
MaCH-Admix IBS-DQ 0.768(0.213) 0.655(0.236) 104526 0.765(0.213) 0.672(0.236) 590
IMPUTE2 0.779(0.203) 0.659(0.232) 53975 0.769(0.209) 0.675(0.225) 869
BEAGLE 0.717(0.232) 0.535(0.243) 162132 0.709(0.237) 0.543(0.269) 452
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120, --imputeStates 500; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE:
niterations=10 nsamples=4. Running time is measured in seconds. Best performance in
each comparison is highlighted by bold font.
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Figure 4.7: Imputation quality of ASW with HapMapII CEU+YRI+LWK+MKK refer-
ence panel. Imputation quality (measured by dosage r2) is plotted as a function of the
effective reference panel size (i.e., #states), for ASW individuals in three selected 5Mb
regions (ordered by LD from high to low).
I also included ancestry-weighted selection in evaluation in this setting because weights
can be estimated stably given the relatively simple population structure in reference. In-
terestingly, I did not observe noticeable advantage of the ancestry-weighted selection
method despite the obvious population structure within the reference panel and the
target being admixed individuals. It however outperforms random selection slightly in
most ASW experiments.
4.3.4 Running Time
Methods implemented in MaCH-Admix have comparable running time to that of IM-
PUTE2. BEAGLE has similar running time in experiments with HapMap references.
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Table 4.7: Imputation Results of 49 ASW Individuals Over All Five Short Regions
HapMapII CEU+YRI reference HapMapIII CEU+YRI reference
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.937(0.106) 0.721(0.230) 168 0.942(0.121) 0.833(0.275) 138
MaCH-Admix AW 0.938(0.102) 0.766(0.191) 126 0.944(0.120) 0.837(0.275) 147
MaCH-Admix IBS-PW 0.940(0.099) 0.787(0.190) 125 0.946(0.111) 0.860(0.249) 158
MaCH-Admix IBS-SQ 0.939(0.100) 0.759(0.184) 128 0.943(0.121) 0.836(0.281) 158
MaCH-Admix IBS-DQ 0.937(0.106) 0.739(0.209) 132 0.946(0.112) 0.857(0.249) 149
IMPUTE2 0.939(0.099) 0.803(0.155) 288 0.942(0.119) 0.850(0.264) 316
BEAGLE 0.906(0.140) 0.702(0.276) 177 0.921(0.141) 0.796(0.296) 131
chromosome1:75-80Mb
MaCH-Admix Random 0.916(0.123) 0.862(0.201) 197 0.921(0.135) 0.810(0.237) 250
MaCH-Admix AW 0.915(0.124) 0.853(0.209) 194 0.922(0.134) 0.812(0.236) 280
MaCH-Admix IBS-PW 0.915(0.123) 0.857(0.202) 199 0.925(0.132) 0.826(0.234) 258
MaCH-Admix IBS-SQ 0.914(0.125) 0.853(0.207) 209 0.923(0.132) 0.819(0.230) 243
MaCH-Admix IBS-DQ 0.914(0.125) 0.858(0.211) 206 0.923(0.135) 0.815(0.240) 246
IMPUTE2 0.914(0.131) 0.839(0.228) 441 0.919(0.140) 0.810(0.253) 442
BEAGLE 0.893(0.150) 0.824(0.245) 178 0.898(0.166) 0.777(0.285) 199
chromosome4:57-62Mb
MaCH-Admix Random 0.898(0.138) 0.808(0.230) 188 0.920(0.125) 0.840(0.239) 226
MaCH-Admix AW 0.898(0.138) 0.814(0.231) 187 0.922(0.123) 0.850(0.239) 210
MaCH-Admix IBS-PW 0.900(0.136) 0.821(0.231) 203 0.922(0.127) 0.847(0.249) 234
MaCH-Admix IBS-SQ 0.899(0.141) 0.811(0.238) 192 0.920(0.127) 0.841(0.243) 230
MaCH-Admix IBS-DQ 0.899(0.140) 0.814(0.232) 317 0.921(0.127) 0.845(0.247) 228
IMPUTE2 0.897(0.140) 0.813(0.233) 415 0.920(0.128) 0.837(0.245) 452
BEAGLE 0.868(0.166) 0.775(0.252) 182 0.900(0.146) 0.803(0.280) 170
chromosome14:50-55Mb
MaCH-Admix Random 0.869(0.180) 0.744(0.298) 227 0.876(0.179) 0.757(0.306) 504
MaCH-Admix AW 0.871(0.176) 0.765(0.279) 232 0.880(0.177) 0.766(0.304) 282
MaCH-Admix IBS-PW 0.873(0.177) 0.762(0.293) 249 0.881(0.178) 0.769(0.304) 296
MaCH-Admix IBS-SQ 0.873(0.176) 0.761(0.289) 240 0.879(0.178) 0.765(0.302) 311
MaCH-Admix IBS-DQ 0.873(0.176) 0.757(0.293) 249 0.878(0.180) 0.757(0.312) 310
IMPUTE2 0.870(0.180) 0.756(0.289) 497 0.879(0.180) 0.766(0.301) 523
BEAGLE 0.841(0.199) 0.688(0.332) 189 0.849(0.201) 0.694(0.340) 214
chromosome8:18-23Mb
MaCH-Admix Random 0.861(0.170) 0.813(0.247) 329 0.849(0.189) 0.766(0.285) 392
MaCH-Admix AW 0.863(0.171) 0.824(0.249) 332 0.850(0.188) 0.765(0.288) 423
MaCH-Admix IBS-PW 0.862(0.170) 0.824(0.247) 332 0.853(0.189) 0.761(0.296) 423
MaCH-Admix IBS-SQ 0.861(0.172) 0.819(0.246) 373 0.849(0.191) 0.778(0.290) 508
MaCH-Admix IBS-DQ 0.862(0.171) 0.821(0.239) 344 0.849(0.190) 0.776(0.289) 418
IMPUTE2 0.860(0.175) 0.793(0.263) 658 0.853(0.194) 0.767(0.299) 767
BEAGLE 0.820(0.200) 0.728(0.303) 241 0.825(0.206) 0.732(0.309) 269
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE: niterations=10 nsam-
ples=4. Best performance in each comparison is highlighted by bold font.
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Table 4.8: Imputation Results of 49 ASW Individuals Over All Five Short Regions
HapMapIII CEU+YRI+LWK+MKK reference
overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.953(0.101) 0.868(0.232) 162
MaCH-Admix AW 0.954(0.097) 0.881(0.222) 159
MaCH-Admix IBS-PW 0.958(0.091) 0.898(0.208) 167
MaCH-Admix IBS-SQ 0.954(0.100) 0.871(0.233) 179
MaCH-Admix IBS-DQ 0.954(0.100) 0.876(0.233) 173
IMPUTE2 0.952(0.100) 0.877(0.225) 291
BEAGLE 0.934(0.124) 0.811(0.271) 334
chromosome1:75-80Mb
MaCH-Admix Random 0.932(0.122) 0.837(0.222) 236
MaCH-Admix AW 0.935(0.119) 0.847(0.217) 238
MaCH-Admix IBS-PW 0.939(0.117) 0.858(0.222) 283
MaCH-Admix IBS-SQ 0.935(0.124) 0.841(0.235) 270
MaCH-Admix IBS-DQ 0.935(0.120) 0.850(0.226) 272
IMPUTE2 0.932(0.124) 0.846(0.225) 553
BEAGLE 0.918(0.144) 0.819(0.259) 491
chromosome4:57-62Mb
MaCH-Admix Random 0.934(0.107) 0.885(0.200) 232
MaCH-Admix AW 0.934(0.110) 0.884(0.208) 251
MaCH-Admix IBS-PW 0.937(0.106) 0.892(0.200) 253
MaCH-Admix IBS-SQ 0.934(0.110) 0.879(0.211) 247
MaCH-Admix IBS-DQ 0.935(0.109) 0.878(0.210) 267
IMPUTE2 0.929(0.120) 0.861(0.237) 426
BEAGLE 0.914(0.132) 0.833(0.256) 469
chromosome14:50-55Mb
MaCH-Admix Random 0.883(0.170) 0.756(0.301) 318
MaCH-Admix AW 0.886(0.168) 0.772(0.295) 309
MaCH-Admix IBS-PW 0.891(0.167) 0.778(0.304) 352
MaCH-Admix IBS-SQ 0.889(0.166) 0.783(0.295) 320
MaCH-Admix IBS-DQ 0.890(0.166) 0.786(0.294) 335
IMPUTE2 0.893(0.168) 0.785(0.303) 642
BEAGLE 0.873(0.181) 0.757(0.305) 514
chromosome8:18-23Mb
MaCH-Admix Random 0.863(0.178) 0.781(0.274) 431
MaCH-Admix AW 0.865(0.180) 0.788(0.285) 417
MaCH-Admix IBS-PW 0.871(0.177) 0.790(0.286) 452
MaCH-Admix IBS-SQ 0.867(0.180) 0.800(0.281) 479
MaCH-Admix IBS-DQ 0.867(0.178) 0.785(0.281) 462
IMPUTE2 0.865(0.186) 0.800(0.286) 923
BEAGLE 0.848(0.190) 0.768(0.292) 718
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE: niterations=10 nsam-
ples=4. Best performance in each comparison is highlighted by bold font.
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Table 4.9: Imputation Results of 50 MEX Individuals Over All Five Short Regions
HapMapII CEU+YRI+JPT+CHB reference HapMapIII CEU+YRI+JPT+CHB reference
overall dosage r2 uncommon SNPs running overall dosage r2 uncommon SNPs running
(std dev) dosage r2(std dev) time (std dev) dosage r2(std dev) time
chromosome3:80-85Mb
MaCH-Admix Random 0.965(0.083) 0.988(0.040) 114 0.956(0.112) 0.893(0.227) 143
MaCH-Admix AW 0.965(0.080) 0.985(0.054) 120 0.957(0.109) 0.898(0.216) 144
MaCH-Admix IBS-PW 0.964(0.082) 0.989(0.037) 125 0.957(0.110) 0.899(0.222) 184
MaCH-Admix IBS-SQ 0.964(0.081) 0.987(0.046) 124 0.957(0.110) 0.897(0.221) 164
MaCH-Admix IBS-DQ 0.963(0.083) 0.989(0.042) 122 0.956(0.112) 0.896(0.223) 167
IMPUTE2 0.961(0.089) 0.986(0.036) 298 0.957(0.119) 0.898(0.237) 311
BEAGLE 0.959(0.093) 0.995(0.012) 225 0.947(0.130) 0.854(0.245) 232
chromosome1:75-80Mb
MaCH-Admix Random 0.927(0.136) 0.832(0.244) 192 0.923(0.165) 0.818(0.296) 255
MaCH-Admix AW 0.929(0.134) 0.827(0.240) 186 0.924(0.168) 0.814(0.306) 248
MaCH-Admix IBS-PW 0.930(0.134) 0.838(0.245) 209 0.926(0.169) 0.819(0.312) 272
MaCH-Admix IBS-SQ 0.926(0.136) 0.838(0.221) 203 0.921(0.171) 0.829(0.308) 251
MaCH-Admix IBS-DQ 0.926(0.139) 0.832(0.230) 220 0.922(0.170) 0.822(0.309) 262
IMPUTE2 0.927(0.141) 0.820(0.250) 471 0.923(0.177) 0.801(0.317) 476
BEAGLE 0.915(0.146) 0.806(0.245) 239 0.908(0.191) 0.775(0.338) 299
chromosome4:57-62Mb
MaCH-Admix Random 0.928(0.147) 0.806(0.296) 183 0.928(0.160) 0.840(0.286) 219
MaCH-Admix AW 0.929(0.146) 0.806(0.286) 189 0.927(0.162) 0.838(0.289) 214
MaCH-Admix IBS-PW 0.928(0.149) 0.802(0.304) 200 0.927(0.161) 0.844(0.287) 238
MaCH-Admix IBS-SQ 0.928(0.148) 0.812(0.286) 286 0.926(0.163) 0.851(0.288) 235
MaCH-Admix IBS-DQ 0.927(0.149) 0.809(0.292) 193 0.928(0.161) 0.839(0.291) 238
IMPUTE2 0.925(0.156) 0.806(0.300) 435 0.925(0.169) 0.832(0.298) 501
BEAGLE 0.920(0.160) 0.793(0.305) 230 0.919(0.172) 0.824(0.304) 320
chromosome14:50-55Mb
MaCH-Admix Random 0.922(0.158) 0.895(0.167) 249 0.916(0.183) 0.823(0.290) 347
MaCH-Admix AW 0.921(0.161) 0.902(0.168) 273 0.915(0.183) 0.816(0.292) 286
MaCH-Admix IBS-PW 0.922(0.163) 0.900(0.171) 252 0.918(0.182) 0.827(0.293) 335
MaCH-Admix IBS-SQ 0.921(0.161) 0.903(0.168) 273 0.915(0.183) 0.828(0.286) 316
MaCH-Admix IBS-DQ 0.920(0.161) 0.898(0.166) 263 0.917(0.181) 0.840(0.287) 315
IMPUTE2 0.922(0.165) 0.901(0.169) 541 0.916(0.182) 0.827(0.290) 598
BEAGLE 0.911(0.170) 0.891(0.172) 276 0.908(0.190) 0.813(0.299) 319
chromosome8:18-23Mb
MaCH-Admix Random 0.900(0.162) 0.852(0.233) 316 0.886(0.191) 0.824(0.284) 402
MaCH-Admix AW 0.901(0.160) 0.858(0.224) 336 0.885(0.196) 0.815(0.294) 401
MaCH-Admix IBS-PW 0.903(0.159) 0.867(0.218) 327 0.888(0.197) 0.826(0.298) 513
MaCH-Admix IBS-SQ 0.900(0.163) 0.863(0.223) 356 0.882(0.198) 0.817(0.298) 465
MaCH-Admix IBS-DQ 0.900(0.161) 0.864(0.212) 329 0.883(0.199) 0.813(0.301) 459
IMPUTE2 0.898(0.164) 0.871(0.199) 716 0.879(0.205) 0.811(0.302) 806
BEAGLE 0.889(0.169) 0.859(0.225) 340 0.870(0.211) 0.788(0.320) 434
All results were generated using the following parameter values: MaCH-Admix: --rounds
30, --states 120; IMPUTE2: -iter 30, -k 120, -k hap 500; BEAGLE: niterations=10 nsam-
ples=4. Best performance in each comparison is highlighted by bold font.
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It however needs significantly more computing time than MaCH-Admix and IMPUTE2
when imputing with the 1000G reference, which I believe has to do with how consecutive
untyped variants are modeled. Note that, due to the large number of experiments, I
conducted all experiments on a big Linux cluster with more than 1000 CPUs. This leads
to moderate fluctuations in running time over short regions due to I/O competition. But
I obtain largely consistent conclusions across different experimental settings.
4.4 Discussion
In summary, the emergence of large reference panels calls for more efficient methods
to utilize the rich resource. I have implemented two classes of reference-selection meth-
ods, namely IBS-based and ancestry-weighted approaches, to construct effective reference
panels within previously described HMM and implemented them in software package
MaCH-Admix for genetic imputation in admixed populations. I have performed sys-
tematic evaluations on large (WHI-AA and WHI-HA full sample with 8421 and 3587
individuals), medium (subset of 200 individuals from each of the two WHI admixed co-
horts), and small (HapMap ASW and MEX with 49 and 50 founders respectively) target
samples; using large (the latest 1000G with H = 2188) and small (HapMap with H =
240-930) reference panels; and in five regions with different levels of LD. Compared with
popular existing methods, MaCH-Admix demonstrates its advantage mostly because its
piecewise algorithm takes potential changes in haplotype pattern sharing across regions
into direct account (versus IMPUTE2 which adopts a whole-haplotype IBS matching
approach) and because it does not reduce local haplotype complexity (versus BEAGLE
which does so to gain computational efficiency). Based on my evaluations, I recom-
mend the proposed piecewise IBS-based method, which demonstrates the best trade off
between quality and computing time.
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As the reference panel continues to grow rapidly (for example, the 1000 Genomes
Project will generate ∼5,000 haplotypes within two years), approaches that can rapidly
explore the entire reference pool will become increasingly appreciated. IBS-based ap-
proaches show such potential. As manifested by results from both WHI individuals and
the HapMapIII individuals, IBS-based approaches can generate accurately imputed geno-
types by preferentially selecting a small but different subset of ∼100 (corresponding to
∼5% for the current 1000G case where H=2188) haplotypes from the entire reference
pool in each iteration. As computational costs increase quadratically with the effective
number of haplotypes used in each iteration, such ∼95% reduction in the effective number
of reference haplotypes corresponds to >99.5% reduction in computational investment.
Previous studies [Hao et al., 2009; Li et al., 2009; Shriner et al., 2010; Zhang et al.,
2011; Seldin et al., 2011] have recommended the use of a combined reference panel which
pools haplotypes from all available reference populations (e.g., from the HapMap or
the 1000 Genomes Projects), especially for populations that do not have a single best
match reference population for increased imputation accuracy. Two forces working in
opposite directions are introduced by including reference haplotypes from populations
different from those in target samples in such a cosmopolitan panel: shared haplotype
stretches (likely even shorter) that would increase imputation quality while noise added by
including population-specific local haplotypes would harm imputation quality. Therefore,
the recommendation of using a cosmopolitan panel to enhance imputation quality also
applies to MaCH-Admix, conceptually more applicable because MaCH-Admix reduces
the noise force by choosing local haplotypes that are most relevant into effective reference.
One key question concerns the optimal region size for imputation. From the per-
spective of including more LD information, particularly the long-range LD information
that would be particularly critical for the imputation of uncommon variants, imputa-
tion over longer regions is desired. However, approaches that select reference haplotypes
according to genetic matching between reference haplotypes and genotypes of target indi-
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viduals across the entire region like whole-haplotype IBS-based methods will likely suffer
from the change in genetic matching over a long region. For example, for both scenarios
presented in Figure 4.1, there are two distinct sub-regions according to the matching pat-
tern. Lumping them naively together, particularly using a single queue, may well lead
to inferior performance as discussed earlier. I attempt to solve the problem by break-
ing the entire region into smaller pieces and within each piece selecting some reference
haplotypes according to local genetic matching. This conceptually shares similarity with
local ancestry adjustment in analysis of admixed populations [Wang et al., 2011a]. Pasa-
niuc et al. [2011] also found local ancestry increases imputation accuracy. The proposed
piecewise IBS based selection method is robust to imputation region size. I have evalu-
ated the performance on whole chromosomes using ASW/MEX with HapMap references
and found that both piecewise IBS and ancestry-weighted selection perform much better
than whole-haplotype IBS based methods (data not shown). Between piecewise IBS and
ancestry-weighted selections, the piecewise IBS method has advantage in most whole
chromosome experiments and is very close to ancestry-weighted selection in the rest.
Ancestry-weighted approaches have been previously utilized to construct reference
panels in admixed populations for tagSNP selection or imputation [Egyud et al., 2009;
Pasaniuc et al., 2010; Pemberton et al., 2008]. However, such reference panels created
a priori induce two problems for imputation. First, haplotypes from contributing ref-
erence populations are literally duplicated, thus substantially increasing computational
burden. Second, the same fixed pre-constructed reference haplotypes are to be used for
all Markov iterations, preventing imputation algorithms from taking into account the
uncertainty in creating the reference panel. My ancestry-weighted approach selects ref-
erence haplotypes probabilistically according to the estimated ancestry proportions and
creates a different reference panel in each Markov iteration. This strategy ensures that
all reference haplotypes to be selected when I run the Markov iterations long enough,
thus avoiding both problems mentioned above. An attractive feature that I have added
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to MaCH-Admix is a functionality to estimate ancestry proportions so that it can inter-
nally generate weights for ancestry-weighted approach without the need to install and
call external programs. Although there exist many methods to infer ancestry includ-
ing for example structure [Pritchard et al., 2000], HAPMIX [Price et al., 2009] and
GEDI-ADMX [Pasaniuc et al., 2009], I believe that researchers will find this build-in
feature convenient. I found my estimates reasonably close to estimates from structure
and working well for imputation purpose.
In this study, I have examined the performance of my proposed and other imputa-
tion methods in both Hispanics and African Americans. Between the two, Hispanics
are known to have more complex LD structure because of three ancestral populations
involved as opposed to two for African Americans. The more complex LD in Hispanics
indeed makes it essential to more explicitly account for the larger variability in local
ancestry (for example, using my proposed piecewise approach). The more complex LD
and population substructure in Hispanics have prevented a lot of investigators from even
attempting imputation. However, I observe similar if not slightly better imputation
quality in the five regions examined, with an average dosage r2 of 92.5% (81.8%) versus
92.1% (81.4%) for all (uncommon) SNPs in WHI-HA and WHI-AA respectively using my
piecewise IBS approach. That imputation performance for Hispanics is comparable with
that for African Americans is expected due to on average less African ancestry (where
LD is the lowest and thus most challenging for imputation) in Hispanics compared to
African Americans. Therefore, I highly encourage investigators working with Hispanics
perform imputation as well.
Although in this work I propose the reference selection methods for imputation of
admixed individuals, the methods can be directly applied to imputation in general for
non-admixed populations by finding the best genetic match for each target individual.
For the same reason, IBS-based methods tend to work better than ancestry-weighted ap-
proaches when between-individual variation among the target individuals is large (data
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not shown). This is not surprising because IBS-based approaches select a different effec-
tive reference panel tailored for each target individual, rather than one uniform reference
sampling setting for all target individuals as in the ancestry-weighted approach.
I have also attempted to examine common and uncommon genetic variants separately,
using MAF 5% as cutoff. I observe more pronounced differences among the attempted
methods with uncommon variants, suggesting that choice of reference selection methods
matters more for uncommon variants. Due to the nature of the SNPs evaluated (ei-
ther typed Affymetrix 6.0 markers for the WHI individuals, or HapMap markers) and
the target sample size (49-50 for HapMapIII ASW and MEX), there are few really rare
(MAF<1%) variants. Although several attempts have been made [Wang et al., 2011b;
Howie et al., 2011; The International HapMap Consortium, 2010; Liu et al., 2012], im-
putation quality for uncommon variants is far from being fully assessed and needs to be
further evaluated when data from large scale sequencing efforts become available.
Last but clearly not the least point concerns computational efficiency. MaCH-Admix
is very flexible in terms of the effective number of haplotypes used in each iteration
and the number of iterations. Imputation accuracy depends on both parameters. Since
computational cost increases quadratically with --states and linearly with --rounds, for
practical purpose, I recommend using --states 100-120 and --rounds ≥20. I also have
an option analogous to IMPUTE2’s -k hap, which increases computational costs linearly
and even defaulting at a large value (500) contributes to only a small proportion of com-
puting time. Between the two categories of approaches proposed, the ancestry-weighted
approach requires only one-time up-front costs for the estimation of ancestry proportions.
The IBS-based methods, on the other hand, require overhead costs at each iteration for
calculating genetic similarities between individuals in the target population and the ref-
erence haplotypes. For both, the costs increase with the reference panel size. Finally,
computational costs would increase only linearly with --states if I start with haplotypes
of the target individuals, that is, for haplotype-to-haplotype (both reference and target
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are in haplotypes) imputation as performed by software minimac. I plan to extend my
proposed methods to minimac in the future.
Web Resources
Census fact for admixed populations,
http://quickfacts.census.gov/qfd/states/00000.html
The 1000 Genomes Project, http://www.1000genomes.org/
MaCH-Admix, http://www.unc.edu/~yunmli/MaCH-Admix/
MaCH, http://www.sph.umich.edu/csg/yli/mach/
IMPUTE, http://mathgen.stats.ox.ac.uk/impute/impute.html
BEAGLE, http://faculty.washington.edu/browning/BEAGLE/BEAGLE.html
structure: http://pritch.bsd.uchicago.edu/software.html
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Chapter 5
Genotype Imputation of Metabochip
SNPs in African Americans Using a
Study Specific Reference Panel
5.1 Introduction
Genotype imputation has become standard practice to increase genome coverage and im-
prove power in Genome-Wide Association Studies (GWAS) and meta-analysis [de Bakker
et al., 2008; Li et al., 2009; Marchini and Howie, 2010]. The wealth of literature using
genotype imputation has focused on using external reference panels (for example, phased
haplotypes from the International HapMap Project [The International HapMap Con-
sortium, 2007] or the 1000 Genomes Project [The 1000 Genomes Project Consortium,
2010]), largely in individuals of European ancestry, for inference of genotypes at common
(MAF > 0.05) genetic markers.
GWAS have identified > 4, 300 genetic variants associated with human diseases
and traits (http://www.genome.gov/gwastudies/) [Hindorff et al., 2009]. Investigators
across the world have begun efforts to fine map within regions where GWAS-identified
SNPs reside, through dense genotyping (e.g., using region-centric or gene-centric chips
like the Metabochip for metabolic related traits
(http://www.sph.umich.edu/csg/kang/MetaboChip/), or the ITMAT-Broad-CARe [IBC]
for cardiovascular related traits, or the immunochip for immune related diseases) or se-
quencing. Furthermore, multiethnic genetic association studies have been recognized as
potentially more powerful for both gene discovery and fine mapping [McCarthy et al.,
2008; Pulit et al., 2010; Rosenberg et al., 2010; Teo et al., 2010] and some initial ef-
forts have been carried out [He et al., 2011; Keebler et al., 2010; Lanktree et al., 2009;
Lettre et al., 2011; Smith et al., 2011; Waters et al., 2009]. In addition, because GWAS-
identified SNPs (mostly common) explain only a small proportion of overall heritability
for most complex diseases and traits [Eichler et al., 2010; Maher, 2008; Manolio et al.,
2009], whole-genome or whole-exome sequencing for rare SNPs and genetic variants other
than SNPs (e.g., copy number variations, structural variants) are under way.
So far, there has been relatively little research on the performance of genotype im-
putation in this new context. My study provides a typical scenario where 8, 421 African
Americans from the Women’s Health Initiative [The WHI Study Group, 1998] SNP
Health Association Resource (SHARe) were genotyped using the Affymetrix 6.0 genotyp-
ing platform. In an attempt to generalize genetic effects across racial groups, the Pop-
ulation Architecture using Genomics and Epidemiology (PAGE) consortium genotyped
a subset of 1,962 African American WHI participants with data on multiple metabolic
related phenotypes using the Metabochip [Matise et al., 2011]. To increase the power to
detect moderate to small genetic effects, I sought to impute the Metabochip SNPs in the
remaining 6,459 individuals in WHI SHARe with Affymetrix 6.0 data only. Imputing
SNPs in the fine mapping region tends to be more challenging because these SNPs tend
to be rare and in low linkage disequilibrium (LD) with GWAS SNPs. Here I describe a
pipeline for constructing study-specific reference panels using individuals genotyped or
sequenced at a larger set of genetic markers (in this case, individuals genotyped using
both Affymetrix 6.0 and Metabochip) and for imputation into individuals with genotype
data at a subset of markers (in this case, individuals genotyped using Affymetrix 6.0
only). I benchmark the quality of my imputation in an African American population, for
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SNPs on the Metabochip, a region-centric genotyping platform, with particular focus on
low frequency SNPs (MAF down to 0.001), using a large study-specific reference panel
containing 3, 924 haplotypes. An African American sample poses a greater challenge for
genotype imputation due to more complex LD patterns in African Americans compared
with individuals of European ancestry [Egyud et al., 2009; Shriner et al., 2010], and in
which comparatively less discovery work has been done.
I first describe how I constructed my study-specific reference panel using the 1, 962
African American individuals with genotypes for both Affymetrix 6.0 and Metabochip
SNPs and how I performed imputation of the Metabochip-only SNPs into the remaining
6, 459 individuals. I then show several approaches through which I estimated imputation
quality for SNPs in different MAF categories, with a special focus on less common (MAF:
0.01 − 0.05) and rare (MAF < 0.01) variants. I provide practical guidelines regarding
post-imputation quality control for different MAF categories, as well as for the inclusion
of rare variants during imputation.
5.2 Materials and Methods
5.2.1 Pre-Imputation Quality Control
Prior to phasing and imputation, quality control was applied to both the Metabochip
data and the GWAS data. Specifically, for the GWAS dataset (n = 6,459) I removed
Affymetrix 6.0 SNPs with genotype call rates < 90% (m = 1,633), or Hardy-Weinberg
exact test [Wigginton, et al. 2005] p-value < 10−6 (m = 16,327), or MAF < 0.01 (m =
14,014), resulting in a 829,370 GWAS SNPs passing quality control criteria [Reiner et al.,
2011]. Separate quality control criteria were applied to the Metabochip SNPs, leading to
182,397 QC+ SNPs with genotype call rates > 95% and Hardy-Weinberg p-value > 10−6
Individuals were excluded if they had a call rate below 95%, showed excess heterozygosity,
were part of an apparent first-degree relative pair, or were ancestry outliers as determined
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by Eigensoft [Price et al., 2006]. Details can be found in the PAGE Metabochip platform
paper [Buyske et al., 2011].
5.2.2 General Pipeline for Reference Construction and Subse-
quent Imputation
Figure 5.1 shows schematically how imputation was performed. In the top left panel,
I first merged genotypes from the Affymetrix GWAS panel (blue) and the Metabochip
(yellow) SNPs genotyped as part of the PAGE study for the 1,962 reference individuals
(i.e., individuals with genotype data from both platforms). I then reconstructed hap-
lotypes encompassing both GWAS and Metabochip SNPs for the reference individuals,
constituting the reference panel of 3,924 haplotypes. In the top right panel, haplotype
reconstruction for target individuals (i.e., individuals with GWAS genotypes only) was
carried out similarly, but at the GWAS markers only. Finally, a haplotype-to-haplotype
(that is, data are in haplotype form for both the reference and target individuals) im-
putation was performed to generate estimated genotypes at the Metabochip SNPs for
the 6,459 target individuals.
5.3 Results
5.3.1 Genomewide Imputation using Large Study-Specific Ref-
erence
After careful matching on strand (so that genotypes from both Affymetrix 6.0 and the
Metabochip are on the same strand), SNP ID, genomic coordinates, and actual geno-
types for SNPs in common, I had a merged set of 987,749 SNPs for the 1,962 reference
individuals. The average concordance rate for the 23,703 SNPs in common was 99.7%.
For discordant genotypes, I kept the GWAS genotypes to match those of the target indi-
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Figure 5.1: Reference construction and imputation pipeline using a study-specific refer-
ence panel. This schematic cartoon shows how I constructed my study-specific reference
panel using five individuals genotyped on both the Affymetrix 6.0 and the Metabochip plat-
form and how I performed imputation into the remaining five individuals with Affymetrix
6.0 data only.
viduals with GWAS data only. Haplotypes were reconstructed on the merged set using
MaCH [Li et al., 2010a]. In parallel, I constructed haplotypes across the 829,370 QC+
GWAS SNPs for all 8,421 individuals. Finally, I used the 3,924 haplotypes across the
merged set of 987,749 SNPs as reference to impute into haplotypes across GWAS SNPs of
the target individuals. The final haplotype-to-haplotype imputation was performed using
the software package minimac, which generates the allele dosages (the fractional counts
of an arbitrary allele at each SNP for each individual, ranging continuously from 0 to
2). Minimac also generates the SNP-level quality metric Rsq, which is the SNP-specific
estimated r2 between allele dosages and the unknown true genotypes. Rsq has been
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recommended as an efficient post-imputation quality control metric. Rsq, estimated r2,
and estimated imputation r2 are used interchangeably in the literature [Browning and
Browning, 2009; Li et al., 2009].
5.3.2 Quality Estimate by Masking Genotypes at 2% GWAS
SNPs
Aside from production (actual imputation presented in the section above), I randomly
masked 2% of the GWAS SNPs among the target individuals in the minimac imputation
step to estimate the true imputation accuracy as well as to evaluate the utility of Rsq as
a quality metric. By comparing imputed dosages with experimental genotypes, previous
studies have proposed several statistics to measure true imputation accuracy [Browning
and Browning, 2009; Li et al., 2009; Lin et al., 2010; Marchini and Howie, 2010], measuring
either the concordance rate, correlation, or degree of agreement. Here, I choose to report
the dosage r2, which is the squared Pearson correlation between the estimated allele
dosages and the true experimental genotypes (recoded as 0, 1, and 2 corresponding to
the number of minor alleles), because it is a more informative measure for low frequency
variants by taking allele frequency into account and because it is directly related to
the effective sample size for subsequent association analysis [Pritchard and Przeworski,
2001]. As dosage r2 is calculated using the true genotypes (assuming the experimental
genotypes are the true genotypes), people also call it true r2. Like Rsq, dosage r2 is
also specific to each SNP.
Figure 5.2 shows the average dosage r2 values for the 2% masked GWAS SNPs by
chromosome. Genomewide average is 93.68% (range 87.18% [chromosome 19] - 95.26%
[chromosome 10]). As expected, larger chromosomes (in terms of physical length) tend
to be slightly easier to impute due to slightly lower recombination rates and therefore
higher level of LD [The International HapMap Consortium, 2005]. Chromosome 19,
with the highest gene density, is most challenging for imputation. Table 5.1 shows the
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average dosage r2 values by MAF. Not surprisingly, lower frequency variants are harder to
impute due to poorer coverage by GWAS SNPs, lower degree of LD, and more challenging
haplotype reconstruction. For example, the average dosage r2 for SNPs with MAF >
0.05 is 95.08% ; while the average for SNPs with MAF 0.005-0.01 is 70.84
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Figure 5.2: Imputation accuracy by chromosome for 2% randomly masked GWAS SNPs.
Imputation accuracy (as measured by average dosage r2) for 2% GWAS SNPs masked at
random is plotted by chromosome.
Table 5.1: Average Dosage r2 by MAF, Estimated by Masking 2% GWAS SNPs
MAF #SNPs Average Std Dev
Dosage r2 Dosage r2
0.005-0.01 17 70.84% 18.23%
0.01-0.03 724 82.97% 16.07%
0.03-0.05 876 90.36% 11.03%
0.05-0.50 14983 95.08% 7.70%
While Figure 5.2 and Table 5.1 show the true imputation accuracy, in practice, re-
searchers are more interested in how well imputation quality metrics can predict true
imputation accuracy (measured by dosage r2). Figure 5.3 assesses the quality metric
Rsq by plotting it against dosage r2. One can see that Rsq can predict dosage r2 quite
well, particularly for common SNPs and those with reasonable Rsq values. For example,
the Pearson correlation is 0.938 for all SNPs (regardless of MAF and Rsq), 0.952 for
SNPs with MAF > 0.03 (regardless of Rsq), and 0.955 for SNPs with MAF > 0.03
and Rsq > 0.3.
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Whereas masking GWAS SNPs is a simple approach to estimate imputation accu-
racy, the approach estimates imputation quality for the “wrong” set of SNPs in that
I am imputing genotypes for Metabochip SNPs, not GWAS SNPs. The two set of
SNPs differ in two major aspects: MAF and physical density distribution. First, in
terms of allele frequency distribution: while Affymetrix 6.0 SNPs, like most commercially
available genomewide genotyping platforms, contain SNPs that are mostly common, the
Metabochip platform contains a much larger proportion of lower frequency variants. For
example, while only 4.3% and 9.9% of the Affymetrix SNPs have MAF < 0.03 and <
0.05 respectively, the proportions are 29.8% and 37.8% for Metabochip SNPs. Figure
5.4 shows the MAF distributions of the Affymetrix 6.0 SNPs and the Metabochip SNPs.
Second, the physical distribution of the SNPs is quite different. The Affymetrix 6.0
SNPs are rather evenly spread across the genome. SNPs on the Metabochip, chosen
for fine mapping of regions identified through GWAS to be associated with metabolic
related traits, scatter unevenly across the genome and are concentrated around GWAS-
identified signals. Figure 5.5 shows two typical regions where the GWAS SNP density
(green) is quite uniform across the region while Metabochip SNP density (red) peaks in
a sub-region chosen for follow-up but drops sharply outside the sub-region of interest.
5.3.3 Quality Estimate by Masking Genotypes at Metabochip
SNPs for a Subset of Reference Individuals
To estimate the imputation quality for the actually imputed Metabochip SNPs, I masked
Metabochip genotypes for 100 reference individuals, imputed them, and compared the
estimated dosages with the masked experimental genotypes. Note that I used haplo-
types constructed from GWAS data only for the 100 individuals. Figure 5.6 shows the
average dosage r2 by chromosome. Again imputation quality is slightly higher for larger
chromosomes and lowest for chromosome 19. Table 5.2 presents imputation accuracy
by MAF, with and without post-imputation filtering according to Rsq. First, it is clear
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Figure 5.3: Rsq by dosage r2 for 2% randomly masked GWAS SNPs. Estimated impu-
tation accuracy (minimac output Rsq) is plotted against the true dosage r2, for the 2%
GWAS SNPs masked at random.
that lower frequency variants are harder to impute. Previous studies have shown ear-
lier that imputation accuracy increases with the reference panel size, especially for the
imputation of lower frequency variants [Li et al., 2009; Marchini and Howie, 2010; The
International HapMap Consortium, 2010]. However, even with a reference panel of 3,924
haplotypes, I am not able to obtain reasonable imputed data for SNPs with MAF under
0.001. Without post-imputation filtering, the average dosage r2 is merely 0.39%. If I
apply a post-imputation filter of Rsq > 0.3 (>0.5), only 0.4% (0.3%) of the SNPs with
MAF < 0.001 pass the filter with an average dosage r2 of 24.85% (30.45%). For this rarest
category of SNPs (MAF < 0.001), even at an Rsq threshold of 0.95, which retains merely
23 out of 18,959 SNPs, I can only achieve an average dosage r2 of 47.82% (Figure 5.7(a)).
Second, SNPs with MAF > 0.01 can be imputed fairly well using a reference panel of this
size. For example, even without any post-imputation quality control filter, the average
dosage r2 is 85.32%, 91.73%, and 94.62% for SNPs with MAF 0.01-0.03, 0.03-0.03, and
97
 0
 5
 10
 15
 20
 0  0.05  0.1  0.15  0.2  0.25  0.3  0.35  0.4  0.45  0.5
Pe
rc
en
ta
ge
Minor Allele Frequency
Metabochip
Affymetrix 6.0
Figure 5.4: MAF distributions of Affymetrix 6.0 and Metabochip QC+ SNPs. I show the
histograms for the MAFs of the 829,370 Affymetrix 6.0 QC+ SNPs (top panel) and of the
182,397 Metabochip QC+ SNPs (bottom panel).
>0.05, indicating that ∼85-95% of the information can be recovered for SNPs in these
MAF categories. Third, I am able to impute a considerable proportion of less common
(MAF 0.001-0.01) variants reasonably well using a reference panel of this size along with
post-imputation quality filtering according to Rsq. For example, I can obtain an average
dosage r2 of 79.71% for 20.5% of the SNPs with MAF 0.001-0.005 by excluding SNPs
with Rsq < 0.5; and an average dosage r2 of 83.05% for 52.0% of the SNPs with MAF
0.005-0.01 by excluding SNPs with Rsq < 0.3, with both Rsq thresholds selected such
that the average Rsq is above 80%.
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Figure 5.5: Physical spreading of Affymetrix 6.0 and Metabochip QC+ SNPs. SNP
frequency is plotted against genomic coordinate for two randomly chosen regions, green for
Affymetrix 6.0 SNPs and red for Metabochip SNPs. The frequency is normalized so that
the total frequency in each region is 1.
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Figure 5.6: Imputation accuracy by chromosome for Metabochip SNPs (estimated by
masking 100 reference individuals). Imputation accuracy (as measured by average dosage
r2) for Metabochip SNPs is plotted by chromosome, by masking 100 reference individuals
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Figure 5.7: Accuracy and calibration of imputation. Percentages of SNPs passing post-
imputation QC (left Y-axis) and average dosage r2 (right Y-axis) are plotted against Rsq
threshold used for post-imputation QC for SNPs in different MAF categories.
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Table 5.2: Average Rsq and Dosage r2 by MAF, Estimated by Masking 100 Reference Individuals
No Rsq Filter Rsq > 0.3 Rsq > 0.5
MAF #SNPs average average %SNPs average average %SNPs average average
Rsq dosage r2 Rsq dosage r2 Rsq dosage r2
0-0.001 18959 0.46% 0.39% 0.4% 72.31% 24.85% 0.3% 83.77% 30.45%
0.001-0.005 6925 21.80% 33.74% 23.8% 82.41% 73.94% 20.5% 89.24% 79.71%
0.005-0.01 7001 47.49% 64.87% 52.0% 87.32% 83.05% 48.2% 91.14% 86.00%
0.01-0.03 19894 77.57% 85.32% 83.6% 91.72% 88.98% 81.2% 93.21% 89.88%
0.03-0.05 13315 92.11% 91.73% 97.5% 94.27% 92.11% 96.3% 94.91% 92.57%
0.05-1.00 92597 96.94% 94.62% 99.9% 97.05% 94.71% 99.4% 97.30% 94.94%
Note: I evaluated a total of 158,691 out of the total 182,397 QC+Metabochip SNPs because 23,706 SNPs are both on the Metabochip
and the Affymetrix 6.0 panel and were excluded from quality evaluation to avoid upward bias.
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5.3.4 Overall Imputation Performance and Practical Guidelines
In practice, I recommend using Rsq as the post-imputation quality control metric. Figure
5.8 attests to the high correlation between Rsq and dosage r2. I observe that the vast ma-
jority of SNPs are both imputed well and are predicted to be well imputed, corresponding
to the biggest point masses (red to yellow range according to SNP frequency/count spec-
trum) with both high Rsq and high dosage r2. Overall, I find that Rsq can predict dosage
r2 fairly well, particularly for common SNPs and those with reasonable Rsq values. For
example, Pearson correlation between Rsq and dosage r2 is 0.86 for SNPs with MAF
0.005-0.01 and Rsq > 0.5; and 0.93 for SNPs with MAF 0.01-0.03 and Rsq > 0.3. I also
observe a noticeable point mass at the right bottom corner, corresponding to SNPs that
are predicted to be poorly imputed (low Rsq) but are actually well imputed (high dosage
r2). Closer examination revealed that most of these SNPs are of low frequency (95.4%
have MAF < 0.03 and 99.7% have MAF < 0.05), for which the imputation model has
low confidence in the estimated dosages that actually match the true dosages fairly well.
Furthermore, I recommend different Rsq thresholds for different MAF categories.
Figure 5.7 presents the percentage of SNPs passing post-imputation QC (left Y axis)
and the average dosage r2 (right Y axis) as a function of Rsq threshold (X axis). To
achieve an average dosage r2 of at least 0.85 for example, one would have to use an Rsq
threshold of 0.7 for SNPs with MAF 0.001-0.005 while an Rsq threshold of 0 suffices
for SNPs with MAF > 0.03. Based on Table 5.2 and Figure 5.7, for my dataset, I
chose an Rsq threshold of 0.5 for SNPs with MAF 0.001-0.005 and an Rsq threshold of
0.3 for SNPs with MAF > 0.005, resulting in a total of 127,132 SNPs (out of 158,691)
passing post-imputation QC. The sample size for SNPs with MAF < 0.001 is too small
for conclusions, but the pattern suggests that the few SNPs passing the post imputation
filter of Rsq > 0.5 are well imputed. In general, I recommend selecting an Rsq threshold
such that the average Rsq is above the desired average dosage r2.
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Figure 5.8: Rsq by dosage r2 for Metabochip SNPs (estimated by masking 100 reference
individuals). Estimated imputation accuracy (minimac output Rsq) is plotted against the
true dosage r2, for Metabochip SNPs by masking 100 reference individuals.
5.3.5 To Include or Not to Include: Rare SNPs during Hap-
lotype Reconstruction
One open question concerns whether rare SNPs should be included for haplotype re-
construction, either for the reference individuals or for the target individuals. For the
reference panel construction, on one hand, one would like to include as many variants
as possible so that they can be subsequently imputed in the target individuals. On
the other hand, inclusion of very rare SNPs may interfere with phasing (in the extreme
case, for example, singletons cannot be phased), resulting in less accurately constructed
haplotypes, and ultimately leading to inferior imputation quality, with little or no ben-
efit in return because these very rare SNPs are unlikely to be accurately imputed into
the target individuals. Similarly, for the target individuals, inclusion of rare SNPs may
103
harm phasing quality, leading to less accurate imputation. On the other hand, as rare
to-be-imputed SNPs are more likely to be tagged by rare GWAS SNPs than by common
GWAS SNPs, inclusion of rare GWAS variants is expected to increase imputation quality
for rarer SNPs. To evaluate this, I assessed the following 20 combinations by varying two
parameters: MAF threshold used for the reference panel construction and MAF thresh-
old used for phasing target individuals. For the reference panel construction, I evaluated
the following four settings: A) all MAF (i.e., no filtering by MAF); B) no singletons (i.e.,
removing SNPs with only one copy of the minor allele among the 8,421 individuals with
GWAS data); C) MAF > 0.001; and D) MAF > 0.005. For phasing target individuals,
I evaluated the following five settings: i) all MAF; ii) no singletons (i.e., removing SNPs
with only one copy of the minor allele among reference); iii) MAF > 0.001; iv) MAF >
0.005; and v) MAF > 0.01. Note that for my production imputation, I used v) MAF >
0.01. I picked a medium size chromosome, chromosome 12, for evaluation.
As the comparisons among the four settings for building the reference panel show
similar patterns across the five settings for target haplotype reconstruction and vice
versa, I present the average of all settings defined by the other parameter. For example,
Table 5.3 shows the effect of including rare variants for reference panel construction,
where the statistics (number of SNPs and average dosage r2) for each of the four settings
are averaged across the five settings for reconstructing target haplotypes. Among the four
settings evaluated, setting B (No Singletons) provides the best trade-off: noticeable gains
for MAF categories 0.001-0.01 at little cost for common SNPs. For example, for SNPs
with MAF 0.001-0.005, at an Rsq threshold of 0.3, setting B leads to 119 well-imputed
SNPs with an average dosage r2 of 84.0%, outperforming setting A which also results
in119 well-imputed SNPs but with a lower average dosage r2 of 82.8%, setting C of 123
well-imputed SNPs with dosage r2 of 82.8%, and setting D of 0 well-imputed SNPs (by
design). For common SNPs with MAF > 0.01, all four settings have similar performance.
On the other hand, there is no clear winner among the five settings for phasing GWAS
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data (Table 5.4). Removing SNPs with MAF < 0.001 or 0.005 (settings iii and iv) is
slightly advantageous for imputing SNPs with MAF 0.001-0.01. For example, with an
Rsq threshold of 0.3, average dosage r2 for SNPs with MAF 0.001-0.005 is 85.6% and
84.0% respectively for setting iii and iv; while dosage r2 for the other three settings are ≤
83.0%. However, these settings result in slightly lower imputation quality for SNPs with
MAF 0.01-0.05. For example, with an Rsq threshold of 0.3, average dosage r2 for SNPs
with MAF 0.01-0.03 is 90.4% (for 1255 SNPs) and 90.6% (for 1269 SNPs) respectively
for setting iii and iv; while dosage r2 for the other three settings are ≥ 91.0% for a larger
number of SNPs (number of SNPs ≥ 1289).
105
Table 5.3: Effect of Including Rare Variants for Reference Panel Construction
A: All MAF B: No Singletons C: MAF > 0.1% D: MAF > 0.5%
MAF Rsq #SNPs average #SNPs average #SNPs average #SNPs average
Threshold dosage r2 dosage r2 dosage r2 dosage r2
0-0.001 0 22 44.0% 22 43.7% 0 NA 0 NA
0.001-0.005 0 266 70.9% 266 72.9% 266 72.3% 0 NA
0.005-0.01 0 494 85.7% 494 85.7% 494 84.8% 494 85.3%
0.01-0.03 0 1521 90.4% 1521 90.3% 1521 90.3% 1521 90.3%
0.03-0.05 0 955 93.4% 955 93.5% 955 93.4% 955 93.4%
0.05-1.00 0 5494 95.5% 5494 95.5% 5494 95.5% 5494 95.5%
0-0.001 0.3 2 100.0% 3 75.8% 0 NA 0 NA
0.001-0.005 0.3 119 82.8% 119 84.0% 123 82.8% 0 NA
0.005-0.01 0.3 333 87.6% 333 87.8% 328 87.6% 335 87.6%
0.01-0.03 0.3 1307 91.1% 1306 91.0% 1307 91.0% 1307 91.0%
0.03-0.05 0.3 941 93.6% 941 93.7% 940 93.8% 941 93.7%
0.05-1.00 0.3 5486 95.6% 5486 95.6% 5487 95.5% 5487 95.5%
0-0.001 0.5 2 100.0% 2 65.8% 0 NA 0 NA
0.001-0.005 0.5 105 85.6% 103 86.4% 105 85.9% 0 NA
0.005-0.01 0.5 310 89.1% 310 89.3% 308 89.1% 311 89.2%
0.01-0.03 0.5 1268 92.1% 1266 92.0% 1268 92.0% 1269 91.9%
0.03-0.05 0.5 931 94.2% 932 94.2% 932 94.2% 931 94.1%
0.05-1.00 0.5 5460 95.9% 5460 95.8% 5461 95.8% 5459 95.8%
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Table 5.4: Effect of Including Rare Variants for Haplotype Reconstruction among Target Individuals
i: All MAF ii: No Singletons iii: MAF > 0.1% iv: MAF > 0.5% v: MAF > 1%
MAF Rsq Threshold #SNPs average #SNPs average #SNPs average #SNPs average #SNPs average
Threshold dosage r2 dosage r2 dosage r2 dosage r2 dosage r2
0-0.001 0 22 45.3% 22 44.9% 22 44.2% 22 47.3% 22 37.5%
0-0.001 0.3 3 100.0% 2 100.0% 3 81.3% 2 75.0% 3 83.3%
0-0.001 0.5 3 100.0% 2 100.0% 3 81.3% 1 83.3% 3 83.3%
0.001-0.005 0 266 73.0% 266 72.7% 266 72.7% 266 71.8% 266 70.1%
0.001-0.005 0.3 102 83.0% 123 81.0% 122 85.6% 120 84.0% 133 82.3%
0.001-0.005 0.5 86 86.4% 104 84.5% 106 87.6% 107 86.5% 118 84.9%
0.005-0.01 0 494 85.5% 494 85.8% 494 86.6% 494 85.5% 494 83.4%
0.005-0.01 0.3 285 84.8% 332 88.8% 346 88.8% 350 88.3% 348 87.5%
0.005-0.01 0.5 264 86.4% 316 89.9% 325 90.1% 326 89.7% 317 89.8%
0.01-0.03 0 1521 90.5% 1521 90.6% 1521 90.3% 1521 90.1% 1521 90.1%
0.01-0.03 0.3 1289 91.4% 1347 91.6% 1255 90.4% 1269 90.6% 1373 91.0%
0.01-0.03 0.5 1256 92.3% 1293 92.7% 1222 91.5% 1231 91.6% 1337 92.1%
0.03-0.05 0 955 93.4% 955 93.6% 955 93.2% 955 93.5% 955 93.5%
0.03-0.05 0.3 938 93.7% 943 93.8% 943 93.4% 933 93.8% 946 93.7%
0.03-0.05 0.5 932 94.1% 932 94.4% 934 93.9% 922 94.4% 938 94.1%
0.05-0.50 0 5494 95.4% 5494 95.5% 5494 95.5% 5494 95.5% 5494 95.5%
0.05-0.50 0.3 5486 95.5% 5490 95.5% 5487 95.5% 5487 95.6% 5484 95.7%
0.05-0.50 0.5 5460 95.8% 5463 95.8% 5461 95.8% 5457 95.9% 5460 95.9%
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Table 5.5: Effect of Including/Excluding the 100 Masked Reference Individuals during
Reference Haplotype Reconstruction
n = 1862 (Excluding) n = 1962 (Including)
MAF Rsq #SNPs average #SNPs average
Threshold dosage r2 dosage r2
0-0.001 0 22 47.4% 22 40.3%
0-0.001 0.3 3 89.2% 2 85.2%
0-0.001 0.5 3 84.2% 2 77.1%
0.001-0.005 0 266 71.6% 266 72.6%
0.001-0.005 0.3 117 84.1% 123 82.3%
0.001-0.005 0.5 100 87.3% 108 84.7%
0.005-0.01 0 494 85.4% 494 85.4%
0.005-0.01 0.3 333 87.8% 332 87.5%
0.005-0.01 0.5 309 89.4% 310 89.0%
0.01-0.03 0 1521 90.3% 1521 90.4%
0.01-0.03 0.3 1305 91.0% 1308 91.1%
0.01-0.03 0.5 1267 92.0% 1268 92.1%
0.03-0.05 0 955 93.4% 955 93.4%
0.03-0.05 0.3 941 93.7% 940 93.7%
0.03-0.05 0.5 932 94.2% 931 94.2%
0.05-0.50 0 5494 95.5% 5494 95.5%
0.05-0.50 0.3 5487 95.5% 5487 95.6%
0.05-0.50 0.5 5459 95.8% 5462 95.8%
Table 5.6: Average Rsq and Dosage r2 by MAF, Estimated by Masking One Reference
Individual at a Time (Chromosome 12)
No Rsq Filter Rsq > 0.5 Rsq > 0.75
MAF #SNPs average average %SNPs average average %SNPs average average
Rsq dosage r2 Rsq dosage r2 Rsq dosage r2
0-0.001 1798 4.58% 2.47% 4.7% 70.58% 38.74% 1.7% 84.57% 47.31%
0.001-0.005 935 64.66% 48.41% 73.5% 76.06% 60.59% 38.8% 87.51% 77.21%
0.005-0.01 639 84.77% 79.81% 95.9% 86.67% 81.92% 80.3% 90.70% 86.66%
0.01-0.03 1586 90.86% 88.56% 99.1% 91.35% 89.13% 91.4% 93.55% 91.62%
0.03-0.05 955 94.60% 92.87% 99.6% 94.76% 93.04% 96.6% 95.63% 93.99%
0.05-1.00 5494 96.31% 94.73% 99.5% 96.64% 95.05% 97.6% 97.21% 95.68%
5.4 Discussion
As we are moving into the sequencing era, existing GWAS data provide an inexpensive
opportunity to leverage expensive sequencing data. Researchers across the world are
becoming increasingly keen on imputation as a tool to infer genotypes at less common
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(MAF 0.01-0.05) and rare (MAF < 0.01) variants. Li et al. [2010b] have previously shown
that larger reference panels improve imputation accuracy for less common variants. In
particular, enlarging a reference panel of 60 haplotypes to 1,000 haplotypes increases
dosage r2 for SNPs with MAF < 0.05 from 74% to 93%. However, there has been
little, if any research, on truly rare variants: it is not until recently that data became
available to assess imputation accuracy for these truly rare variants. Here, I used a
reference panel of 3,924 reference haplotypes to demonstrate that it is indeed possible to
impute a considerable proportion of rare variants reasonably well, even in a challenging
admixed sample of African Americans. Specifically (as indicated in bold in Table2), I
was able to impute 99.9% (97.5%, 83.6%, 52.0%, 20.5%) of SNPs with MAF > 0.05
(0.03-0.05, 0.01-0.03, 0.005-0.01, and 0.001-0.005) with average dosage r2 94.7% (92.1%,
89.0%, 83.1%, and 79.7%).
In the previous section, I presented results from masking Metabochip genotypes for
100 reference individuals during minimac imputation, whom I also included along with
the other 1,862 individuals during reference panel construction. One may reasonably
argue that the inclusion of the 100 individuals during phasing results in local haplotype
mosaics of other individuals better matching haplotypes of these 100 individuals (because
constructed haplotypes of the 100 individuals are likely to serve as template to construct
haplotypes of other individuals), and therefore over-estimated imputation accuracy. I
evaluated this potential over-estimation of imputation accuracy by re-constructing the
reference panel only on the other 1,862 individuals. Table 5.5 compares imputation
accuracy at Metabochip SNPs for the 100 masked individuals with (phasing ref n =
1,962) or without (phasing ref n = 1,862) them during phasing. I observed no obvious
over-estimation: the quality is either very close; or one has slightly smaller number of
well-imputed SNPs with slightly higher dosage r2 than the other. For example, for
SNPs with MAF 0.001-0.005, when using Rsq > 0.3 as the post-imputation filter, the
reference constructed using 1862 individuals resulted in slightly fewer (117) SNPs passing
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the filter with a slightly better average dosage r2 (84.1%), than the reference constructed
using 1962 individuals which had 123 SNPs passing the filter with an average dosage r2 of
82.3%. The over-estimation may manifest itself if the reference panel were smaller because
the 100 masked individuals would contribute more to the haplotype reconstruction of
other reference individuals.
I would also like to note that masking 100 reference individuals, although allowing us
to directly evaluate imputation quality at actually imputed Metabochip SNPs, still has
limitations. For example, sample MAF cannot go below 0.005 and SNPs with “popula-
tion” MAF (calculated based on n = 1,962 individuals) < 0.005 are either non-varying
or have the minor allele over-represented among the 100 individuals (i.e., sample MAF
> “population” MAF). Therefore, such SNPs are either not imputable (dosage r2 un-
defined and set to zero in my calculations) or tend to be easier to impute than a typical
SNP in the population MAF category. The latter case leads to a winner’s curse phe-
nomenon such that the actual imputation quality tends to be over-estimated. In order to
obtain more reliable estimates for the rarest MAF categories, I attempted a slightly more
complicated experiment on chromosome 12 where I masked one reference individual at a
time and imputed her genotypes at Metabochip SNPs using other reference individuals’
haplotypes. This experiment allows us to examine a sample size of 1,962 instead of 100.
The overall recommendation of picking an Rsq threshold such that the average Rsq
is at least 80% to achieve an average dosage r2 of 80% or above still applies. However,
compared with results based on 100 individuals, the actual Rsq thresholds selected for
the rare MAF categories are considerably larger, but result in the passing of a larger
proportion of SNPs. For example, an Rsq threshold of 0.75 (instead of 0.5 based on the
100 individuals) needs to be applied for SNPs with MAF 0.001-0.005 for the average Rsq
to be above 80%, passing 38.8% (instead of 20.5% SNPs). The larger Rsq threshold and
larger passing proportion are consistent with the winner’s curse phenomenon I discuss
above. For example, for SNPs with population MAF 0.001-0.005, the vast majority of
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SNPs are monomorphic among the 100 individuals and thus have Rsq close to zero,
reflected by the fact that 68.7% of SNPs have Rsq < 0.1 (Figure 5.7(b)). For the small
proportion of SNPs that have reasonable Rsq (Rsq > 0.3), which is the proportion of
SNPs with minor allele either over-represented or in more extensive LD with neighboring
SNPs among the sample of 100 masked individuals), the distribution is highly skewed
towards high values. For example, among the 20.5% SNPs with Rsq > 0.5, 16.9% (or
82.0% of the 20.5%) have Rsq > 0.75 such that the average Rsq is 89.24%. In contrast, a
much larger proportion of SNPs are no longer monomorphic among the 1,962 individuals
and better represent the full range of SNPs in these rare MAF categories, specifically
by adding the more challenging SNPs (SNPs with less or no over-representation of the
minor allele, and SNPs with less extensive LD with neighboring SNPs). For example,
now only 1.8% (compared with 68.7% above based on 100 individuals) SNPs have Rsq
< 0.1 for SNPs with MAF 0.001-0.005. Among the 73.5% (compared with 20.5% above)
of SNPs with Rsq > 0.5, 38.8% (or 52.8% of the 73.5%) have Rsq > 0.75 (Table 5.6).
Although this study examines an African American population genotyped using Affy-
metrix 6.0 platform, the recommendation to use Rsq threshold such that average Rsq
is around but over the desired dosage r2 value is generalizable to other populations and
other GWAS genotyping platforms, based on similar experiments conducted in several
European and Asian populations using different choices of genotyping platforms. For
example, in a sample of Filipinos [Wu et al., 2010] genotyped using the Affymetrix 5.0
platform, I found applying a filter of Rsq > 0.6 for SNPs with MAF 0.01-0.02, the av-
erage dosage r2 across the SNPs passing the filter was 0.8085 with an average Rsq of
0.8417. Additional assessment in other populations or using other GWAS platforms can
be found in earlier studies [Li et al., 2011, 2010a]. Before more data become available,
however, caution needs to be taken when applying the recommendation to rare variants.
For example, although imputation in general is more difficult in African populations be-
cause of more combinations of the common alleles, recent work [Fumagalli et al., 2010;
111
Gravel et al., 2011] argue that the more distinctive background of common alleles may
benefit imputation of rare variants. In addition, tagSNPs on the Affymetrix 6.0 platform
were selected largely based on physical positions, in contrast to those on the Illumina
platforms which were selected largely to provide good coverage of the common SNPs
according to HapMap-based LD. Therefore, the Affymetrix 6.0 platform may perform
better for rare SNP imputation, particularly in samples of non-European ancestry.
My sample consist of females only, therefore, it is straightforward to perform im-
putation on chromosome X. Even for samples including males, widely used imputation
methods can now perform X chromosome imputation (see
http://genome.sph.umich.edu/wiki/MaCH:_machX and Marchini and Howie [2010]). I
did not attempt chromosome X in my dataset because there are only 93 QC+ Metabochip
SNPs on chromosome X.
In summary, by constructing a study-specific reference panel of 3,924 haplotypes, I
found it feasible to impute SNPs on the Metabochip, a region-centric dense genotyping
platform, in a sample of African Americans, including less common SNPs with MAF
0.005-0.05. In addition, I confirmed Rsq as an effective imputation quality metric for
these less common variants. In particular, I recommend different Rsq thresholds for
different MAF categories such that the average Rsq is above 80%. Furthermore, I found
it helpful to remove singleton SNPs when constructing reference haplotypes.
I view this work useful for investigators conducting fine-mapping studies using either
dense genotyping or next generation sequencing, particularly for studies in non-European
populations. Many efforts to fine map, especially in non-European ancestry participants,
are limited by small sample sizes. Now that there are increasing numbers of GWAS
studies conducted in non-European populations, imputation can provide a good solu-
tion to this sample size problem. For admixed samples like those in this study, new
methods are being developed that both leverage the admixture for phenotype-genotype
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association mapping and take imputation uncertainty into account [Manolio et al., 2009;
Pasaniuc et al., 2011].
113
Chapter 6
Conclusion
In this dissertation, I present efficient algorithms for genetic analyses in two common
genetic study scenarios:
1. Model organisms that are bred through prescribed pedigree design.
2. Humans that are drawn from out-bred populations or continental groups.
By reconstructing haplotype information implicitly or explicitly via HMM, I address
two core problems, genome ancestry and genotype imputation, for the two scenarios
respectively. In the genome ancestry problem (Chapter 2), I prune the state space in
HMM by contracting an important repetitive sub-structure, inbreeding. The major limit
of my inbreeding model is that it does not accelerate the ancestry inference for all types
of pedigrees. But the computational benefit brought can be crucial in important existing
model organism resources such as the Collaborative Cross. I have demonstrated both
the effectiveness and efficiency of the algorithm on synthetic and real Collaborative Cross
datasets. In the genotype imputation problem (Chapter 4), I accelerate the computation
using piecewise “greedy” selection of individual-tailored references. My method is most
effective with the emerging sequencing-based large-scale reference panels such as the
1000G panel [The 1000 Genomes Project Consortium, 2010, 2012]. Experiments on
admixed populations suggest that my method, implemented in the software package
MaCH-Admix, can achieve comparable imputation accuracy by selecting 1/10 of the
total references or less, which corresponds to substantial saving in computation effort.
Compared with existing methods, my method has particularly noteworthy advantage
among uncommon variants.
In addition to the methodology work, I have presented subsequent analysis of Col-
laborative Cross data using the ancestry inferred. My analysis (Chapter 3) establishes
a new linkage map of the laboratory mouse genome and reveals important properties of
recombination events. I have also presented a case study of genotype imputation in a
large cohort (∼4000) of African Americans (Chapter 5). My study not only examines
imputation performance in under-studied aspects, but also provides practical guidelines
for both conducting imputation and post-imputation quality control.
6.1 Future Directions
Below I discuss potential subsequent analysis and future research avenues of the studies
presented in this dissertation.
6.1.1 Model Organisms from Prescribed Breeding
The ancestry knowledge estimated by my method GAIN has played a key role in studying
the complex traits present in emerging CC lines [Aylor et al., 2011; The Collaborative
Cross Consortium, 2012]. In this dissertation, I have also presented analysis on recombi-
nation events in early generations of CC resource. As the CC lines continue to develop
and, more importantly, become recombinant inbred, I could conduct more powerful sub-
sequent studies in various aspects of studying genetic variations. Also, as I have discussed
previously, modeling repetitive sub-structure is a promising approach not only for CC but
also for complex pedigrees in many other model organism resources. For example, I may
extend my method to handle the repetitive selfing process in plant resources [Cavanagh
et al., 2008; Kover et al., 2009].
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6.1.2 Samples from Out-bred Human Populations
One limitation of my imputation model is the assumption that a individual-tailored small
subset of the reference haplotypes is enough in explaining each target individual. The
assumption generally holds well for short or high-LD imputation regions in which the
haplotype diversity is low. For longer regions with higher haplotype diversity, using a
small subset of reference haplotypes could result in loss in imputation accuracy, especially
for rare variants. The loss can be partially compensated by the haplotype-based impu-
tation step in MaCH-Admix which utilizes a much larger set of reference haplotypes. I
would also like to explore a more robust framework that can eliminate the dependency
on the assumption. In addition, with the emergence of reference panels like 1000G [The
1000 Genomes Project Consortium, 2010, 2012] which contains samples from multiple
continental groups and populations, my imputation method can be naturally adapted
for population ancestry estimation. Compared with existing methods [Price et al., 2009;
Sundquist et al., 2008], my imputation-based framework could be more flexible in han-
dling multiple ancestral sources.
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